OOIR: Observatory of International Research

Papers

(The TQCC of Arteriosclerosis Thrombosis and Vascular Biology is 88. The table below lists those papers that are above that threshold based on CrossRef citation counts. The publications cover those that have been published in the past four years, i.e., from 2019-03-01 to 2023-03-01.)

Article	Citations
Lessons From Sudden Coronary Death	2842
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients	2225
C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction	1664
Endothelial Dysfunction	1535
Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness	1162
Association of Hypoadiponectinemia With Coronary Artery Disease in Men	1049
Atherosclerotic Plaque Progression and Vulnerability to Rupture	1008
Obesity and Systemic Oxidative Stress	1002
Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited	929
Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis	914
The Response-to-Retention Hypothesis of Early Atherogenesis	909
Adiponectin and Metabolic Syndrome	853
Oxidative Stress and Vascular Disease	847
A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes	801
Laminar Shear Stress	765
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis	725
Vascular Calcification	663
Brain Cholesterol: Long Secret Life Behind a Barrier	656
Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology	648
Cholesteryl Ester Transfer Protein	628
Role of the Toll-like Receptor 4/NF-κB Pathway in Saturated Fatty Acid–Induced Inflammatory Changes in the Interaction Between Adipocytes and Macrophages	619
Noninvasive Assessment of Arterial Stiffness and Risk of Atherosclerotic Events	587
Ankle-Arm Index as a Predictor of Cardiovascular Disease and Mortality in the Cardiovascular Health Study	571
Endothelial Progenitor Cells	562
Myeloperoxidase and Cardiovascular Disease	551
Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice	543
Paraoxonase and Atherosclerosis	541
High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules	533
Upregulation of VCAM-1 and ICAM-1 at Atherosclerosis-Prone Sites on the Endothelium in the ApoE-Deficient Mouse	532
Obesity and Cardiovascular Disease	526
Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the Elderly	522
Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis	510
High Density Lipoproteins and Arteriosclerosis	502
Natural History and Histological Classification of Atherosclerotic Lesions	495
Reactive Oxygen Species Activate the HIF-1α Promoter Via a Functional NFκB Site	478
Statins Upregulate PCSK9 , the Gene Encoding the Proprotein Convertase Neural Apoptosis-Regulated Convertase-1 Implicated in Familial Hypercholesterolemia	477
Peripheral Arterial Disease in the Elderly	472
Inflammation and Matrix Metalloproteinases in the Enlarging Abdominal Aortic Aneurysm	468
Platelets and Thrombin Generation	462
Inflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms	462
Olive Oil and Red Wine Antioxidant Polyphenols Inhibit Endothelial Activation	461
Distinct Subcellular Localizations of Nox1 and Nox4 in Vascular Smooth Muscle Cells	456
Novel Autologous Cell Therapy in Ischemic Limb Disease Through Growth Factor Secretion by Cultured Adipose Tissue–Derived Stromal Cells	455
Inflammation and Restenosis in the Stent Era	453
The Yin and Yang of Oxidation in the Development of the Fatty Streak	451
White Cell Telomere Length and Risk of Premature Myocardial Infarction	446
Abdominal Aortic Aneurysm	442
Vascular Inflammation and the Renin-Angiotensin System	437
Nuclear Factor κB Signaling in Atherogenesis	437
Omega-3 Fatty Acids and Cardiovascular Disease	437
Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase	435
Site Specificity of Atherosclerosis	426
Role of Tissue Factor in Hemostasis, Thrombosis, and Vascular Development	425
Lipid Oxidation Products Have Opposite Effects on Calcifying Vascular Cell and Bone Cell Differentiation	424
Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway	413
Quantitative Evaluation of Carotid Plaque Composition by In Vivo MRI	410
Osteo/Chondrocytic Transcription Factors and Their Target Genes Exhibit Distinct Patterns of Expression in Human Arterial Calcification	398
Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk	398
Definition of Metabolic Syndrome	395
Reduced Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice Following Consumption of Red Wine, or Its Polyphenols Quercetin or Catechin, Is Associated With Reduced Susceptibility of LDL	394
Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels	392
Importance of Different Pathways of Cellular Cholesterol Efflux	392
Morphologic Findings of Coronary Atherosclerotic Plaques in Diabetics	392
Medial Artery Calcification	389
Regulation of Endothelial Nitric Oxide Synthase by Tetrahydrobiopterin in Vascular Disease	386
Does ADMA Cause Endothelial Dysfunction?	383
Scavenger Receptors in Atherosclerosis	382
Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine	381
Elevated C-Reactive Protein	380
Role of ApoCs in Lipoprotein Metabolism	377
The Dynamics of Thrombin Formation	376
Platelets in Inflammation and Thrombosis	371
Formation of Hyaluronan- and Versican-Rich Pericellular Matrix Is Required for Proliferation and Migration of Vascular Smooth Muscle Cells	370
Apolipoprotein E Alleles and Risk of Coronary Disease	369
Apolipoproteins B, (a), and E Accumulate in the Morphologically Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis	368
Mouse Models of Abdominal Aortic Aneurysms	367
Inhibition of Tumor Necrosis Factor-α Reduces Atherosclerosis in Apolipoprotein E Knockout Mice	366
Role of Lipoprotein-Associated Phospholipase A ₂ in Atherosclerosis	365
Interleukin-6 Exacerbates Early Atherosclerosis in Mice	364
Vascular Protection	363
Improvement of Nitric Oxide–Dependent Vasodilatation by HMG-CoA Reductase Inhibitors Through Attenuation of Endothelial Superoxide Anion Formation	362
Endothelium-Derived Hyperpolarizing Factor	361
Atherosclerosis in the Apolipoprotein E–Deficient Mouse	358
Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans	358
Warfarin Causes Rapid Calcification of the Elastic Lamellae in Rat Arteries and Heart Valves	358
C-Reactive Protein in the Arterial Intima	357
Angiotensin II Stimulates Endothelial Vascular Cell Adhesion Molecule-1 via Nuclear Factor-κB Activation Induced by Intracellular Oxidative Stress	356
Heterogeneity of Endothelial Cells	355
Metformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall Cells	351
Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease	347
The Farnesoid X Receptor	346
Evidence for Association Between Polycystic Ovary Syndrome and Premature Carotid Atherosclerosis in Middle-Aged Women	346
Influence of Fibrin Network Conformation and Fibrin Fiber Diameter on Fibrinolysis Speed	343
Bone Marrow–Derived Progenitor Cells Modulate Vascular Reendothelialization and Neointimal Formation	342
Lifetime Smoking Exposure Affects the Association of C-Reactive Protein with Cardiovascular Disease Risk Factors and Subclinical Disease in Healthy Elderly Subjects	341
Procoagulant Microparticles	340
Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease	339
Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome	338
HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages	336
Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase Activities	336
Phagocytosis of Apoptotic Cells by Macrophages Is Impaired in Atherosclerosis	334
Associations of C-Reactive Protein With Measures of Obesity, Insulin Resistance, and Subclinical Atherosclerosis in Healthy, Middle-Aged Women	332
Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy	331
Aortic Dissection Precedes Formation of Aneurysms and Atherosclerosis in Angiotensin II-Infused, Apolipoprotein E-Deficient Mice	329
Smoking Cessation Rapidly Increases Circulating Progenitor Cells in Peripheral Blood in Chronic Smokers	326
ABCA1 and ABCG1 Synergize to Mediate Cholesterol Export to ApoA-I	325
Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial Stiffness	324
The Unstable Atheroma	321
C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary Arteries	321
Absence of Age-Related Increase in Central Arterial Stiffness in Physically Active Women	319
Soy Isoflavones Improve Systemic Arterial Compliance but Not Plasma Lipids in Menopausal and Perimenopausal Women	319
Hypochlorous Acid, a Macrophage Product, Induces Endothelial Apoptosis and Tissue Factor Expression	318
Human Atherosclerotic Plaque Contains Viable Invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis	317
Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress	316
Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein	316
Endothelial α _ν β ₃ Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis	315
Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages	313
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association	313
Aspirin and Clopidogrel	312
Interrelationships Among Circulating Interleukin-6, C-Reactive Protein, and Traditional Cardiovascular Risk Factors in Women	312
Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis	311
Shear-Induced Platelet Activation and Platelet Microparticle Formation at Blood Flow Conditions as in Arteries With a Severe Stenosis	311
Interactions of Oxidants With Vascular Signaling Systems	307
Oxidized LDL in Carotid Plaques and Plasma Associates With Plaque Instability	306
Pleiotropic Actions of Peroxisome Proliferator–Activated Receptors in Lipid Metabolism and Atherosclerosis	306
Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in Men	304
Monocyte Chemoattractant Protein-1 Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice	303
Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor	303
Signal Transduction Pathways Mediated by PECAM-1	302
Pericellular Proteases in Angiogenesis and Vasculogenesis	301
A Comparison of Three Different Methods to Evaluate Endothelium-Dependent Vasodilation in the Elderly	301
Expression of Multiple Isoforms of Nitric Oxide Synthase in Normal and Atherosclerotic Vessels	298
Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells	296
Arterial Smooth Muscle Cell Heterogeneity	295
HDL and the Inflammatory Response Induced by LDL-Derived Oxidized Phospholipids	295
Notch Signaling in Vascular Development	292
Endothelium-Dependent Effects of Statins	290
Oral Infection With a Periodontal Pathogen Accelerates Early Atherosclerosis in Apolipoprotein E–Null Mice	289
RANK Ligand and Osteoprotegerin	288
Remodeling With Neointima Formation in the Mouse Carotid Artery After Cessation of Blood Flow	287
Platelet Microparticles	287
Patterns and Risk Factors for Systemic Calcified Atherosclerosis	286
Production of Chemokines by Perivascular Adipose Tissue	286
Biomarkers of Atherosclerotic Plaque Instability and Rupture	285
Lysosomal Cysteine Proteases in Atherosclerosis	285
Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic Men	283
Circulating Oxidized Low Density Lipoprotein Levels	282
Association of Cholesteryl Ester Transfer Protein– Taq IB Polymorphism With Variations in Lipoprotein Subclasses and Coronary Heart Disease Risk	282
Caveolin, Caveolae, and Endothelial Cell Function	281
The Unfolded Protein Response Is an Important Regulator of Inflammatory Genes in Endothelial Cells	281
Simvastatin Reduces Expression of Cytokines Interleukin-6, Interleukin-8, and Monocyte Chemoattractant Protein-1 in Circulating Monocytes From Hypercholesterolemic Patients	280
Race, Visceral Adipose Tissue, Plasma Lipids, and Lipoprotein Lipase Activity in Men and Women	279
Urinary Albumin Excretion	277
Regulation of Superoxide Anion Production by NADPH Oxidase in Monocytes/Macrophages	276
Molecular Mechanisms of Vascular Calcification	276
Vascular Consequences of Endothelial Nitric Oxide Synthase Uncoupling for the Activity and Expression of the Soluble Guanylyl Cyclase and the cGMP-Dependent Protein Kinase	275
Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins	274
The Effect of α-Tocopherol Supplementation on LDL Oxidation	272
Plasma Sphingomyelin Level as a Risk Factor for Coronary Artery Disease	272
Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients	272
Periodontal Disease Is Associated With Brachial Artery Endothelial Dysfunction and Systemic Inflammation	270
Peroxisome Proliferator–Activated Receptor Activators Target Human Endothelial Cells to Inhibit Leukocyte–Endothelial Cell Interaction	270
C-Reactive Protein Is Associated With Arterial Stiffness in Apparently Healthy Individuals	269
Endothelial Cell Glycocalyx Modulates Immobilization of Leukocytes at the Endothelial Surface	267
Interleukin-10 Blocks Atherosclerotic Events In Vitro and In Vivo	267
What Does It Take to Make the Perfect Clot?	266
Lipoprotein Heterogeneity and Apolipoprotein B Metabolism	265
Effects of Serum Lipoproteins and Smoking on Atherosclerosis in Young Men and Women	265
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis	264
Medroxyprogesterone Acetate Antagonizes Inhibitory Effects of Conjugated Equine Estrogens on Coronary Artery Atherosclerosis	264
Inhibition of Rho-Kinase Leads to Rapid Activation of Phosphatidylinositol 3-Kinase/Protein Kinase Akt and Cardiovascular Protection	264
Oxidation of LDL by Myeloperoxidase and Reactive Nitrogen Species	263
Isolated Low HDL Cholesterol As a Risk Factor for Coronary Heart Disease Mortality	262
Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery Disease	262
HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells	262
Reactive Oxygen Species	261
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease	261
Apoptosis of Vascular Smooth Muscle Cells Induced by In Vitro Stimulation With Interferon-γ, Tumor Necrosis Factor–α, and Interleukin-1β	261
Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice	261
Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering	261
Vascular Endothelial Cells Respond to Spatial Gradients in Fluid Shear Stress by Enhanced Activation of Transcription Factors	259
Identifying Inflamed Carotid Plaques Using In Vivo USPIO-Enhanced MR Imaging to Label Plaque Macrophages	259
PAI-1 and the Metabolic Syndrome	258
Progression of Aortic Calcification Is Associated With Metacarpal Bone Loss During Menopause	258
C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease	257
Thrombomodulin-Protein C-EPCR System	256
Associations Between Cardiorespiratory Fitness and C-Reactive Protein in Men	256
Role of Naturally Occurring CD4 ⁺ CD25 ⁺ Regulatory T Cells in Experimental Atherosclerosis	256
Common Promoter Variant in Cyclooxygenase-2 Represses Gene Expression	256
Associations of Coronary Heart Disease Risk Factors With the Intermediate Lesion of Atherosclerosis in Youth	256
Increase of Circulating Endothelial Progenitor Cells in Patients with Coronary Artery Disease After Exercise-Induced Ischemia	255
Metabolic Cardiovascular Syndrome and Risk of Dementia in Japanese-American Elderly Men	255
Dynamics and Plasticity of Weibel-Palade Bodies in Endothelial Cells	254
The Interstitium of the Human Arterial Wall Contains Very Large Amounts of Extracellular Superoxide Dismutase	254
Statins Inhibit Secretion of Metalloproteinases-1, -2, -3, and -9 From Vascular Smooth Muscle Cells and Macrophages	253
PPARγ Activation in Human Endothelial Cells Increases Plasminogen Activator Inhibitor Type-1 Expression	253
Lipoprotein-Associated Phospholipase A ₂ Protein Expression in the Natural Progression of Human Coronary Atherosclerosis	253
Nox4 Is Required for Maintenance of the Differentiated Vascular Smooth Muscle Cell Phenotype	252
Altered Fibrin Architecture Is Associated With Hypofibrinolysis and Premature Coronary Atherothrombosis	252
In Vivo Formation of 8-Epi-Prostaglandin F _2α Is Increased in Hypercholesterolemia	252
Flow Effects on Coagulation and Thrombosis	251
Decreased Number and Impaired Angiogenic Function of Endothelial Progenitor Cells in Patients With Chronic Renal Failure	251
NO Generation From Nitrite and Its Role in Vascular Control	250
Evidence for a Functional Role of Endothelial Transient Receptor Potential V4 in Shear Stress–Induced Vasodilatation	250
B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null Mice	249
Role of JNK, p38, and ERK in Platelet-Derived Growth Factor–Induced Vascular Proliferation, Migration, and Gene Expression	249
Strong Induction of Members of the Chitinase Family of Proteins in Atherosclerosis	249
Transforming Growth Factor-β Mediates Balance Between Inflammation and Fibrosis During Plaque Progression	248
Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal Women	248
Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non–Insulin-Dependent Diabetes Mellitus	248
Redox Mechanisms in Blood Vessels	247
Summary of American Heart Association Diet and Lifestyle Recommendations Revision 2006	247
Presence of Oxidized Low Density Lipoprotein in Nonrheumatic Stenotic Aortic Valves	246
Circulating Oxidized LDL Is Associated With Subclinical Atherosclerosis Development and Inflammatory Cytokines (AIR Study)	246
Progression of Coronary Artery Calcium and Risk of First Myocardial Infarction in Patients Receiving Cholesterol-Lowering Therapy	246
Factors Regulating Arteriogenesis	245
Human Atherosclerotic Plaque Contains Both Oxidized Lipids and Relatively Large Amounts of α-Tocopherol and Ascorbate	245
Upregulation of Endothelial Receptor for Oxidized LDL (LOX-1) by Oxidized LDL and Implications in Apoptosis of Human Coronary Artery Endothelial Cells	245
Role of Oxidative Stress in the Pathogenesis of Abdominal Aortic Aneurysms	244
Sensitivity and Specificity of the Ankle–Brachial Index to Predict Future Cardiovascular Outcomes	244
Dose-Response Relationship Between Ischemic Heart Disease Mortality and Long-term Arsenic Exposure	244
Plasma Level of Endogenous Secretory RAGE Is Associated With Components of the Metabolic Syndrome and Atherosclerosis	244
Role of Heat Shock Proteins in Atherosclerosis	243
Circulating CD31 ⁺ /Annexin V ⁺ Apoptotic Microparticles Correlate With Coronary Endothelial Function in Patients With Coronary Ar	243
Role of NO in Flow-Induced Remodeling of the Rabbit Common Carotid Artery	242
Expression of Neutrophil Gelatinase–Associated Lipocalin in Atherosclerosis and Myocardial Infarction	242
Reduced Vascular Remodeling, Endothelial Dysfunction, and Oxidative Stress in Resistance Arteries of Angiotensin II–Infused Macrophage Colony-Stimulating Factor–Deficient Mice	242
Relation of Lipoprotein Subclasses as Measured by Proton Nuclear Magnetic Resonance Spectroscopy to Coronary Artery Disease	241
Microalbuminuria and Peripheral Arterial Disease Are Independent Predictors of Cardiovascular and All-Cause Mortality, Especially Among Hypertensive Subjects	241
Gene Transfer and Hepatic Overexpression of the HDL Receptor SR-BI Reduces Atherosclerosis in the Cholesterol-Fed LDL Receptor–Deficient Mouse	240
Insulin Resistance Syndrome Predicts the Risk of Coronary Heart Disease and Stroke in Healthy Middle-Aged Men	240
Free Fatty Acid Impairment of Nitric Oxide Production in Endothelial Cells Is Mediated by IKKβ	239
Paraoxonase (PON1) Phenotype Is a Better Predictor of Vascular Disease Than Is PON1 ₁₉₂ or PON1 ₅₅	239
Human Paraoxonase-3 Is an HDL-Associated Enzyme With Biological Activity Similar to Paraoxonase-1 Protein but Is Not Regulated by Oxidized Lipids	239
Involvement of RhoA/Rho Kinase Signaling in VEGF-Induced Endothelial Cell Migration and Angiogenesis In Vitro	238
Effect of Immunization With Homologous LDL and Oxidized LDL on Early Atherosclerosis in Hypercholesterolemic Rabbits	238
Expression of ICAM-1 and VCAM-1 and Monocyte Adherence in Arteries Exposed to Altered Shear Stress	236
High-Density Lipoprotein Subpopulation Profile and Coronary Heart Disease Prevalence in Male Participants of the Framingham Offspring Study	236
Nuclear Magnetic Resonance Spectroscopy of Lipoproteins and Risk of Coronary Heart Disease in the Cardiovascular Health Study	235
Vaccine-Induced Antibodies Inhibit CETP Activity In Vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis	235
Hemodynamic Shear Stresses in Mouse Aortas	233
Human Serum Paraoxonase/Arylesterase’s Retained Hydrophobic N -Terminal Leader Sequence Associates With HDLs by Binding Phospholipids	233
Mercury, Fish Oils, and Risk of Acute Coronary Events and Cardiovascular Disease, Coronary Heart Disease, and All-Cause Mortality in Men in Eastern Finland	232
Vastatins Inhibit Tissue Factor in Cultured Human Macrophages	231
Promoter Polymorphisms of Human Paraoxonase PON1 Gene and Serum Paraoxonase Activities and Concentrations	230
Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I	229
Fractalkine in Vascular Biology	229
Troglitazone Inhibits Atherosclerosis in Apolipoprotein E–Knockout Mice	229
Differential Effects of Doxycycline, a Broad-Spectrum Matrix Metalloproteinase Inhibitor, on Angiotensin II–Induced Atherosclerosis and Abdominal Aortic Aneurysms	228
Influence of Oscillatory and Unidirectional Flow Environments on the Expression of Endothelin and Nitric Oxide Synthase in Cultured Endothelial Cells	228
Peroxisome Proliferator-Activated Receptor γ Ligands Increase Release of Nitric Oxide From Endothelial Cells	227
Risk Factors for Abdominal Aortic Aneurysms in Older Adults Enrolled in the Cardiovascular Health Study	227
Elevated Serum C-Reactive Protein Levels and Early Arterial Changes in Healthy Children	226
The Failure of Torcetrapib	225
Novel Conformation-Specific Antibodies Against Matrix γ-Carboxyglutamic Acid (Gla) Protein	225
Diet and Murine Atherosclerosis	224
Osteoprotegerin Inactivation Accelerates Advanced Atherosclerotic Lesion Progression and Calcification in Older ApoE ^−/− Mice	224
Estrogen and Angiogenesis	223
Oxysterols	223
Unraveling the Reactions of Nitric Oxide, Nitrite, and Hemoglobin in Physiology and Therapeutics	222
Thrombin-Induced Increase in Endothelial Permeability Is Associated With Changes in Cell-to-Cell Junction Organization	222
Fibronectin	221
Epidermal Growth Factor Receptor Transactivation by Angiotensin II Requires Reactive Oxygen Species in Vascular Smooth Muscle Cells	221
Matrix Metalloproteinase-2 and −9 Differentially Regulate Smooth Muscle Cell Migration and Cell-Mediated Collagen Organization	220
c-Src Induces Phosphorylation and Translocation of p47phox	220
Human CRP Gene Polymorphism Influences CRP Levels	220
Nitric Oxide Induces the Synthesis of Vascular Endothelial Growth Factor by Rat Vascular Smooth Muscle Cells	219
Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality	217
Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial	217
Central Roles of α ₅ β ₁ Integrin and Fibronectin in Vascular Development in Mouse Embryos and Embryoid Bodies	217
Potential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis	216
Production of the Long Pentraxin PTX3 in Advanced Atherosclerotic Plaques	216
Pathogenesis of Calcific Aortic Valve Disease	215
Intracellular Cholesterol Transport	214
Unique Morphology and Focal Adhesion Development of Valvular Endothelial Cells in Static and Fluid Flow Environments	214
Detection of Superoxide in Vascular Tissue	213
Differential Activation of Mitogenic Signaling Pathways in Aortic Smooth Muscle Cells Deficient in Superoxide Dismutase Isoforms	213
Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease	213
Interleukin-1β in Coronary Arteries of Patients With Ischemic Heart Disease	212
Advanced Atherosclerotic Lesions in the Innominate Artery of the ApoE Knockout Mouse	212
Role of Endothelial Nitric Oxide Synthase in Endothelial Cell Migration	211
Influence of Interferon-γ on the Extent and Phenotype of Diet-Induced Atherosclerosis in the LDLR-Deficient Mouse	211
Complement and Atherogenesis	210
The Diagnostic Accuracy of Ex Vivo MRI for Human Atherosclerotic Plaque Characterization	210
Association Between Serum Uric Acid, Metabolic Syndrome, and Carotid Atherosclerosis in Japanese Individuals	209
Energy Restriction and Weight Loss on Very-Low-Fat Diets Reduce C-Reactive Protein Concentrations in Obese, Healthy Women	209
Upregulation of Superoxide Dismutase and Nitric Oxide Synthase Mediates the Apoptosis-Suppressive Effects of Shear Stress on Endothelial Cells	209
Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice	209
Genetic Cholesteryl Ester Transfer Protein Deficiency Is Extremely Frequent in the Omagari Area of Japan	209
Angiopoietin-Like Protein3 Regulates Plasma HDL Cholesterol Through Suppression of Endothelial Lipase	209
Impact of Body Mass Index on Coronary Heart Disease Risk Factors in Men and Women	208
Oxidative Stress in Human Abdominal Aortic Aneurysms	208
Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper	207
Apolipoprotein A-I Mimetic Peptides	207
Effect of Rosiglitazone on Common Carotid Intima-Media Thickness Progression in Coronary Artery Disease Patients Without Diabetes Mellitus	206
Increased Superoxide Production in Coronary Arteries in Hyperhomocysteinemia	205
Shear Stress Induces Endothelial Differentiation From a Murine Embryonic Mesenchymal Progenitor Cell Line	204
Risk Factors Related to Carotid Intima-Media Thickness and Plaque in Children With Familial Hypercholesterolemia and Control Subjects	204
Hepatic Steatosis: A Mediator of the Metabolic Syndrome. Lessons From Animal Models	203
Role of Matrix Metalloproteinases in Blood Flow–Induced Arterial Enlargement	203
Bisphosphonates Alendronate and Ibandronate Inhibit Artery Calcification at Doses Comparable to Those That Inhibit Bone Resorption	203
The Role of Interleukin 12 in the Development of Atherosclerosis in ApoE-Deficient Mice	203
Differential Accumulation of Proteoglycans and Hyaluronan in Culprit Lesions	203
Increased Expression of the DNA-Binding Cytokine HMGB1 in Human Atherosclerotic Lesions	203
von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects	203
Transforming Growth Factor-βs and Vascular Disorders	202
Selective Retention of VLDL, IDL, and LDL in the Arterial Intima of Genetically Hyperlipidemic Rabbits In Vivo	202
Receptor for Advanced Glycation End Products Mediates Inflammation and Enhanced Expression of Tissue Factor in Vasculature of Diabetic Apolipoprotein E–Null Mice	202
Progression of Atheroma	201
Immunization of LDL Receptor–Deficient Mice With Homologous Malondialdehyde-Modified and Native LDL Reduces Progression of Atherosclerosis by Mechanisms Other Than Induction of High Titers of Antibodi	201
Measuring Plasma Fibrinogen to Predict Stroke and Myocardial Infarction	200
Regulation of Blood Coagulation by the Protein C Anticoagulant Pathway	200
Expression of CCR2 by Endothelial Cells	200
Toll-Like Receptor 4–Dependent and –Independent Cytokine Secretion Induced by Minimally Oxidized Low-Density Lipoprotein in Macrophages	200
Vascular Endothelial Growth Factor/Vascular Permeability Factor Produces Nitric Oxide–Dependent Hypotension	200
Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux	199
Efflux and Atherosclerosis	199
Systemic Inflammatory Parameters in Patients With Atherosclerosis of the Coronary and Peripheral Arteries	199
Effects of Coronary Heart Disease Risk Factors on Atherosclerosis of Selected Regions of the Aorta and Right Coronary Artery	199
Evidence of Hypoxic Areas Within the Arterial Wall In Vivo	198
Elevated Fasting Total Plasma Homocysteine Levels and Cardiovascular Disease Outcomes in Maintenance Dialysis Patients	198
Cyclooxygenase-2 Is Widely Expressed in Atherosclerotic Lesions Affecting Native and Transplanted Human Coronary Arteries and Colocalizes With Inducible Nitric Oxide Synthase and Nitrotyrosine Particu	198
LDL Cholesterol as a Strong Predictor of Coronary Heart Disease in Diabetic Individuals With Insulin Resistance and Low LDL	197
Nuclear Receptors Nur77, Nurr1, and NOR-1 Expressed in Atherosclerotic Lesion Macrophages Reduce Lipid Loading and Inflammatory Responses	197
Transforming Growth Factor β and Atherosclerosis: So Far, So Good for the Protective Cytokine Hypothesis	196
β-Glycerophosphate Accelerates Calcification in Cultured Bovine Vascular Smooth Muscle Cells	196
Inhibition of Atherosclerosis in ApoE-Null Mice by Immunization with ApoB-100 Peptide Sequences	196
Genetic Contribution of the Endothelial Constitutive Nitric Oxide Synthase Gene to Plasma Nitric Oxide Levels	195
Neutrophil Extracellular Traps	195
Evaluation of Endothelial Shear Stress and 3D Geometry as Factors Determining the Development of Atherosclerosis and Remodeling in Human Coronary Arteries in Vivo	195
ACE Gene Polymorphism in Cardiovascular Disease	194
Activation of PPARβ/δ Induces Endothelial Cell Proliferation and Angiogenesis	194
Regulation of Endothelial Cell Survival and Apoptosis During Angiogenesis	193
Elevated Factor VIII Levels and the Risk of Thrombosis	193
Regulation of Vascular Smooth Muscle Cell Migration and Proliferation In Vitro and in Injured Rat Arteries by a Synthetic Matrix Metalloproteinase Inhibitor	193
Antidiabetic PPARγ-Activator Rosiglitazone Reduces MMP-9 Serum Levels in Type 2 Diabetic Patients With Coronary Artery Disease	193
Lysophosphatidic Acid Induces Thrombogenic Activity Through Phosphatidylserine Exposure and Procoagulant Microvesicle Generation in Human Erythrocytes	193
Circulating Vascular Cell Adhesion Molecule-1 Correlates With the Extent of Human Atherosclerosis in Contrast to Circulating Intercellular Adhesion Molecule-1, E-Selectin, P-Selectin, and Thrombomodul	193
The Transcription Factor NF-κB and the Regulation of Vascular Cell Function	192
Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial	192
Telomere Shortening in Human Coronary Artery Diseases	192
Association of the Toll-Like Receptor 4 Gene Asp299Gly Polymorphism With Acute Coronary Events	192
Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease	192
Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery Disease	192
Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion	192
Tissue Factor Encryption	191
Elevated Circulating Levels of Inflammatory Cytokines in Patients With Abdominal Aortic Aneurysm	191
Human Endothelial Progenitor Cells Tolerate Oxidative Stress Due to Intrinsically High Expression of Manganese Superoxide Dismutase	191
Overproduction of VLDL ₁ Driven by Hyperglycemia Is a Dominant Feature of Diabetic Dyslipidemia	191
Matrix Metalloproteinase 2 Activation of Transforming Growth Factor-β1 (TGF-β1) and TGF-β1–Type II Receptor Signaling Within the Aged Arterial Wall	191
Influence of Cardiovascular Risk Factors on Endothelial Progenitor Cells	190
Missense Mutations in the PCSK9 Gene Are Associated With Hypocholesterolemia and Possibly Increased Response to Statin Therapy	190
Effect of Human Recombinant Interleukin-6 and Interleukin-8 on Monocyte Procoagulant Activity	190
Heart Rate Variability and Progression of Coronary Atherosclerosis	190
Influence of the HDL Receptor SR-BI on Lipoprotein Metabolism and Atherosclerosis	189
Physical Inactivity Increases Oxidative Stress, Endothelial Dysfunction, and Atherosclerosis	189
Identification of Unique Lipoprotein Subclasses for Visceral Obesity by Component Analysis of Cholesterol Profile in High-Performance Liquid Chromatography	189
The Effects of Folic Acid Supplementation on Plasma Total Homocysteine Are Modulated by Multivitamin Use and Methylenetetrahydrofolate Reductase Genotypes	188
Effects of Reducing Dietary Saturated Fatty Acids on Plasma Lipids and Lipoproteins in Healthy Subjects	188
T Cells in Atherogenesis	187
Manipulating Angiogenesis	186
Chemokines	186
Serum Paraoxonase After Myocardial Infarction	186
Soy Protein Versus Soy Phytoestrogens in the Prevention of Diet-Induced Coronary Artery Atherosclerosis of Male Cynomolgus Monkeys	186
Matrix Metalloproteinase-2 Production and Its Binding to the Matrix Are Increased in Abdominal Aortic Aneurysms	186
Relation of Plaque Lipid Composition and Morphology to the Stability of Human Aortic Plaques	185
Functional Properties of Human Vascular Endothelial Cadherin (7B4/Cadherin-5), an Endothelium-Specific Cadherin	185
Biomechanical Determinants of Abdominal Aortic Aneurysm Rupture	184
Statins and Blood Coagulation	184
High-Density Lipoprotein Stimulates Endothelial Cell Migration and Survival Through Sphingosine 1-Phosphate and Its Receptors	184
Hemostatic Factors as Predictors of Ischemic Heart Disease and Stroke in the Edinburgh Artery Study	184
Vascular Endothelial Growth Factor–Expressing Mesenchymal Stem Cell Transplantation for the Treatment of Acute Myocardial Infarction	184
HDL Apolipoproteins and ABCA1	183
Plaque Rupture in Humans and Mice	183
Role of Serum Amyloid A During Metabolism of Acute-Phase HDL by Macrophages	183
Plasma Concentration of Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Is Elevated in Monkeys With Hyperhomocyst(e)inemia or Hypercholesterolemia	183
Circulating Cell Adhesion Molecules Are Correlated With Ultrasound-Based Assessment of Carotid Atherosclerosis	183
The Adipocyte and Hemostatic Balance in Obesity	182
Are Retinal Arteriolar Abnormalities Related to Atherosclerosis?	182
Endothelial Protection by High-Density Lipoproteins	181
Cyclophilin A Is a Proinflammatory Cytokine that Activates Endothelial Cells	181
Hyperleptinemia as a Component of a Metabolic Syndrome of Cardiovascular Risk	181
ApoE Polymorphism and Fish Oil Supplementation in Subjects With an Atherogenic Lipoprotein Phenotype	181
Sphingolipids in Atherosclerosis and Vascular Biology	180
Potassium Channel Function in Vascular Disease	180
PI3K-Akt Pathway Suppresses Coagulation and Inflammation in Endotoxemic Mice	180
LDL Immunization Induces T-Cell–Dependent Antibody Formation and Protection Against Atherosclerosis	180
Homocysteine as a Risk Factor for Vascular Disease	180
Oxidized LDL Binds to CD36 on Human Monocyte-Derived Macrophages and Transfected Cell Lines	180
Implications of Early Structural-Functional Changes in the Endothelium for Vascular Disease	179
Stable Compounds of Cigarette Smoke Induce Endothelial Superoxide Anion Production via NADPH Oxidase Activation	179
Relation of High TG–Low HDL Cholesterol and LDL Cholesterol to the Incidence of Ischemic Heart Disease	179
Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris	179
Contribution of Gene Sequence Variations of the Hepatic Cytochrome P450 3A4 Enzyme to Variability in Individual Responsiveness to Clopidogrel	179
Anoïkis in the Cardiovascular System	178
Macrophage Scavenger Receptor Class A	178
Bilirubin From Heme Oxygenase-1 Attenuates Vascular Endothelial Activation and Dysfunction	178
Expression of Interleukin-10 in Advanced Human Atherosclerotic Plaques	178
Histamine Induces Tyrosine Phosphorylation of Endothelial Cell-to-Cell Adherens Junctions	177
Angiotensin II Induces Endothelial Xanthine Oxidase Activation	177
Smooth Muscle Cells in Atherosclerosis Originate From the Local Vessel Wall and Not Circulating Progenitor Cells in ApoE Knockout Mice	177
Cholesteryl Ester Transfer Protein Decreases High-Density Lipoprotein and Severely Aggravates Atherosclerosis in APOE3-Leiden* Mice	177
Relative Contribution of Insulin and Its Precursors to Fibrinogen and PAI-1 in a Large Population With Different States of Glucose Tolerance	177
Increased Platelet Aggregability Associated With Platelet GPIIIa Pl ^A2 Polymorphism	177
Shear Stress Activates p60src-Ras-MAPK Signaling Pathways in Vascular Endothelial Cells	176
HMG CoA Reductase Inhibitors Reduce Plasminogen Activator Inhibitor-1 Expression by Human Vascular Smooth Muscle and Endothelial Cells	175
Macrophage Liver X Receptor Is Required for Antiatherogenic Activity of LXR Agonists	175
In the Elderly, Interleukin-6 Plasma Levels and the −174G>C Polymorphism Are Associated With the Development of Cardiovascular Disease	175
A General Strategy for Isolation of Endothelial Cells From Murine Tissues	175
LXR-Induced Redistribution of ABCG1 to Plasma Membrane in Macrophages Enhances Cholesterol Mass Efflux to HDL	174
Circumferential Stress and Matrix Metalloproteinase 1 in Human Coronary Atherosclerosis	174
Deficiency of Inflammatory Cell Adhesion Molecules Protects Against Atherosclerosis in Mice	174
Elevated Fluid Shear Stress Enhances Postocclusive Collateral Artery Growth and Gene Expression in the Pig Hind Limb	174
Inhibition of Thromboxane Biosynthesis and Platelet Function by Simvastatin in Type IIa Hypercholesterolemia	173
Coadministration of Angiopoietin-1 and Vascular Endothelial Growth Factor Enhances Collateral Vascularization	173
Integrin–Matrix Interactions in the Cerebral Microvasculature	172
Statins Reduce Interleukin-6–Induced C-Reactive Protein in Human Hepatocytes	172
Impact of Mouse Strain Differences in Innate Hindlimb Collateral Vasculature	172
Relation of Glycohemoglobin and Adiposity to Atherosclerosis in Youth	171
Leptin Promotes Vascular Remodeling and Neointimal Growth in Mice	171
Reduced Macrophage Apoptosis Is Associated With Accelerated Atherosclerosis in Low-Density Lipoprotein Receptor-Null Mice	171
Calcification of Human Vascular Cells In Vitro Is Correlated With High Levels of Matrix Gla Protein and Low Levels of Osteopontin Expression	171
Genistein, the Dietary-Derived Angiogenesis Inhibitor, Prevents LDL Oxidation and Protects Endothelial Cells From Damage by Atherogenic LDL	171
Association of C-Reactive Protein With Carotid Atherosclerosis in Men and Women: The Framingham Heart Study	171
Lipoprotein-Associated Phospholipase A ₂ , Platelet-Activating Factor Acetylhydrolase, Is Expressed by Macrophages in Human and Rabbit Atherosclerotic Lesions	171
Statins Reduce Inflammation in Atheroma of Nonhuman Primates Independent of Effects on Serum Cholesterol	170
Interaction of Oxidative Stress and Inflammatory Response in Coronary Plaque Instability	170
Lesional Overexpression of Matrix Metalloproteinase-9 Promotes Intraplaque Hemorrhage in Advanced Lesions But Not at Earlier Stages of Atherogenesis	169
Dose-Dependent Regulation of NAD(P)H Oxidase Expression by Angiotensin II in Human Endothelial Cells	169
The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis	168
Shear Stress Gradients Remodel Endothelial Monolayers in Vitro via a Cell Proliferation-Migration-Loss Cycle	168
Characteristics of Intact and Ruptured Atherosclerotic Plaques in Brachiocephalic Arteries of Apolipoprotein E Knockout Mice	168
Decreased Reverse Cholesterol Transport from Tangier Disease Fibroblasts	168
Soluble Vascular Cell Adhesion Molecule-1 as a Biohumoral Correlate of Atherosclerosis	168
Vascular Endothelial Growth Factor Activates PI3K/Akt/Forkhead Signaling in Endothelial Cells	168
Single and Combined Prothrombotic Factors in Patients With Idiopathic Venous Thromboembolism	168
Lipid Inflammatory Mediators in Diabetic Vascular Disease	167
Rapid Analysis of Angiogenesis Drugs in a Live Fluorescent Zebrafish Assay	167
Activation of Matrix-Degrading Metalloproteinases by Mast Cell Proteases in Atherosclerotic Plaques	167
Relation of Intima-Media Thickness to Atherosclerotic Plaques in Carotid Arteries	167
Relation Between Insulin Resistance, Hyperinsulinemia, Postheparin Plasma Lipoprotein Lipase Activity, and Postprandial Lipemia	167
AMP-Activated Protein Kinase Is Involved in Endothelial NO Synthase Activation in Response to Shear Stress	167
CLA-1 Is an 85-kD Plasma Membrane Glycoprotein That Acts as a High-Affinity Receptor for Both Native (HDL, LDL, and VLDL) and Modified (OxLDL and AcLDL) Lipoproteins	167
Reactive Oxygen Species Regulate Heat-Shock Protein 70 via the JAK/STAT Pathway	166
Scavenger Receptor Class B Type I–Mediated Protection Against Atherosclerosis in LDL Receptor–Negative Mice Involves Its Expression in Bone Marrow–Derived Cells	166
Lipoprotein(a)	165
Nitric Oxide Synthases and Cardiac Muscle	165
Genetic Ablation of Caveolin-1 Confers Protection Against Atherosclerosis	165
Hyperglycemia Reduces Survival and Impairs Function of Circulating Blood-Derived Progenitor Cells	165
Overexpression of 15-Lipoxygenase in Vascular Endothelium Accelerates Early Atherosclerosis in LDL Receptor–Deficient Mice	165
Transfer of Endothelial Progenitor and Bone Marrow Cells Influences Atherosclerotic Plaque Size and Composition in Apolipoprotein E Knockout Mice	165
Role of Leukotriene B ₄ Receptors in the Development of Atherosclerosis: Potential Mechanisms	165
Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and Cancer	164
Isoflavones Reduce Arterial Stiffness	164
Phagocytosis and Macrophage Activation Associated With Hemorrhagic Microvessels in Human Atherosclerosis	164
The Thromboxane Receptor Antagonist S18886 but Not Aspirin Inhibits Atherogenesis in Apo E–Deficient Mice	164
Proatherogenic Role of Elevated CE Transfer From HDL to VLDL ₁ and Dense LDL in Type 2 Diabetes	164
The Lamina Adventitia Is the Major Site of Immune Cell Accumulation in Standard Chow-Fed Apolipoprotein E–Deficient Mice	164
Serum Total IGF-I, Free IGF-I, and IGFBP-1 Levels in an Elderly Population	164
Effect of Oral Postmenopausal Hormone Replacement on Progression of Atherosclerosis	163
Angiotensinogen Gene Polymorphism, Plasma Angiotensinogen, and Risk of Hypertension and Ischemic Heart Disease	163
Action of Atorvastatin in Combined Hyperlipidemia	163
Effect of the Novel Antiplatelet Agent Cilostazol on Plasma Lipoproteins in Patients With Intermittent Claudication	163
Role of Group II Secretory Phospholipase A ₂ in Atherosclerosis	163
Atherosclerosis in Patients With Autoimmune Disorders	162
Compared With Dietary Monounsaturated and Saturated Fat, Polyunsaturated Fat Protects African Green Monkeys From Coronary Artery Atherosclerosis	162
Nonfasting Apolipoprotein B and Triglyceride Levels as a Useful Predictor of Coronary Heart Disease Risk in Middle-Aged UK Men	162
Association Between Elevated Liver Enzymes and C-Reactive Protein	162
Only the Two End Helixes of Eight Tandem Amphipathic Helical Domains of Human Apo A-I Have Significant Lipid Affinity	162
Metabolic Syndrome Scientific Statement by the American Heart Association and the National Heart, Lung, and Blood Institute	161
Elevated Interleukin-18 Levels Are Associated With the Metabolic Syndrome Independent of Obesity and Insulin Resistance	161
Interactions Between Dietary Fat, Fish, and Fish Oils and Their Effects on Platelet Function in Men at Risk of Cardiovascular Disease	161
Macrophage ABCG1 Deletion Disrupts Lipid Homeostasis in Alveolar Macrophages and Moderately Influences Atherosclerotic Lesion Development in LDL Receptor-Deficient Mice	161
Triglyceride:High-Density Lipoprotein Cholesterol Effects in Healthy Subjects Administered a Peroxisome Proliferator Activated Receptor δ Agonist	161
Dietary Factors That Promote or Retard Inflammation	160
Development of the Lipid-Rich Core in Human Atherosclerosis	160
Effect of Simvastatin Therapy on Paraoxonase Activity and Related Lipoproteins in Familial Hypercholesterolemic Patients	160
Genes, Environment, and Cardiovascular Disease	159
Noncholesterol Sterols and Cholesterol Lowering by Long-Term Simvastatin Treatment in Coronary Patients	159
Warfarin-Induced Artery Calcification Is Accelerated by Growth and Vitamin D	158
Smooth Muscle Cell Origin and Its Relation to Heterogeneity in Development and Disease	158
Insulin-Mediated Stimulation of Protein Kinase Akt	158
Peroxynitrite Causes Endoplasmic Reticulum Stress and Apoptosis in Human Vascular Endothelium	158
Molecular Characterization and Localization of the NAD(P)H Oxidase Components gp91- phox and p22- phox in Endothelial Cells	158
Fibrinolytic Activation Markers Predict Myocardial Infarction in the Elderly	158
Increased Atherosclerosis in ApoE and LDL Receptor Gene Knock-Out Mice as a Result of Human Cholesteryl Ester Transfer Protein Transgene Expression	158
Flow-Induced Vascular Remodeling in the Mouse	157
Temporal Gradient in Shear But Not Steady Shear Stress Induces PDGF-A and MCP-1 Expression in Endothelial Cells	157
Lipoprotein-Associated Phospholipase A ₂ Predicts Future Cardiovascular Events in Patients With Coronary Heart Disease Independently of Traditional Risk Factors, Mar	157
Heme Oxygenase and Atherosclerosis	156
Monounsaturated Versus Polyunsaturated Dietary Fat and Serum Lipids	156
Impaired Responsiveness to NO in Newly Diagnosed Patients With Rheumatoid Arthritis	156
Asymmetrical Dimethylarginine in Idiopathic Pulmonary Arterial Hypertension	156
Arterial Mechanical Changes in Children With Familial Hypercholesterolemia	156
At Least 2 Distinct Pathways Generating Reactive Oxygen Species Mediate Vascular Cell Adhesion Molecule-1 Induction by Advanced Glycation End Products	156
Expression of Extracellular SOD and iNOS in Macrophages and Smooth Muscle Cells in Human and Rabbit Atherosclerotic Lesions	156
Smooth Muscle Cell Heterogeneity	155
Patients With Early-Onset Peripheral Vascular Disease Have Increased Levels of Autoantibodies Against Oxidized LDL	155
Increased Endothelial Tetrahydrobiopterin Synthesis by Targeted Transgenic GTP-Cyclohydrolase I Overexpression Reduces Endothelial Dysfunction and Atherosclerosis in ApoE-Knockout Mice	155
In Vivo Characterization and Quantification of Atherosclerotic Carotid Plaque Components With Multidetector Computed Tomography and Histopathological Correlation	155
Heparin-Binding Domains in Vascular Biology	154
Thrombotic Risk in Hereditary Antithrombin III, Protein C, or Protein S Deficiency	154
Apolipoprotein B100 Metabolism in Autosomal-Dominant Hypercholesterolemia Related to Mutations in PCSK9	154
Plasma Total Homocysteine, B Vitamins, and Risk of Coronary Atherosclerosis	154
Oxidized LDL Modulates Bax/Bcl-2 Through the Lectinlike Ox-LDL Receptor-1 in Vascular Smooth Muscle Cells	154
Redox Status and Protein Binding of Plasma Homocysteine and Other Aminothiols in Patients With Early-Onset Peripheral Vascular Disease	154
Supplementation With Low Doses of Vitamin E Protects LDL From Lipid Peroxidation in Men and Women	154
Identification of Immune Responses Against Aldehyde-Modified Peptide Sequences in ApoB Associated With Cardiovascular Disease	154
Intravascular Modalities for Detection of Vulnerable Plaque	153
Apolipoprotein(a) Kringle IV Repeat Number Predicts Risk for Coronary Heart Disease	153
Inherited Apolipoprotein A-V Deficiency in Severe Hypertriglyceridemia	153
Heterogeneity at the CETP Gene Locus	153
Association of C-Reactive Protein With Blood Pressure and Hypertension	153
Homocysteine and Its Disulfide Derivatives	153
Hopelessness and 4-Year Progression of Carotid Atherosclerosis	152
Age and Sex Distribution of Subclinical Aortic Atherosclerosis	152
Determinants of Bioactivity of Oxidized Phospholipids	152
von Willebrand Factor	151
Treatment With Statins After Induction of Focal Ischemia in Rats Reduces the Extent of Brain Damage	151
Transcriptional Regulation of Tissue Factor Expression in Human Endothelial Cells	150
Mitogen-Activated Protein Kinases Mediate Matrix Metalloproteinase-9 Expression in Vascular Smooth Muscle Cells	150
Prospective Study of Fibrinolytic Factors and Incident Coronary Heart Disease	150
Glucose-6-Phosphate Dehydrogenase Overexpression Decreases Endothelial Cell Oxidant Stress and Increases Bioavailable Nitric Oxide	150
Niacin Decreases Removal of High-Density Lipoprotein Apolipoprotein A-I But Not Cholesterol Ester by Hep G2 Cells	150
Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure	150
High Glucose Induces Human Endothelial Cell Apoptosis Through a Phosphoinositide 3-Kinase–Regulated Cyclooxygenase-2 Pathway	150
Severe Hypercholesterolemia in Four British Families With the D374Y Mutation in the PCSK9 Gene	150
Shear Stress Increases ICAM-1 and Decreases VCAM-1 and E-selectin Expressions Induced by Tumor Necrosis Factor-α in Endothelial Cells	150
Fast Food, Central Nervous System Insulin Resistance, and Obesity	149
Role of Platelet P-Selectin and CD40 Ligand in the Induction of Monocytic Tissue Factor Expression	149
Function of the Plasminogen/Plasmin and Matrix Metalloproteinase Systems After Vascular Injury in Mice With Targeted Inactivation of Fibrinolytic System Genes	149
Oleic Acid Inhibits Endothelial Activation	149
Association of Polymorphisms at the SR-BI Gene Locus With Plasma Lipid Levels and Body Mass Index in a White Population	149
Platelet Inhibition by Insulin Is Absent in Type 2 Diabetes Mellitus	148
Increased Serum Levels of Heat Shock Protein 70 Are Associated With Low Risk of Coronary Artery Disease	148
Conditional Knockout of Macrophage PPARγIncreases Atherosclerosis in C57BL/6 and Low-Density Lipoprotein Receptor–Deficient Mice	148
Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes	148
C-Reactive Protein, Cardiovascular Risk Factors, and Mortality in a Prospective Study in the Elderly	147
Effect of MMP-2 Deficiency on Atherosclerotic Lesion Formation in ApoE-Deficient Mice	147
Fas Is Expressed in Human Atherosclerotic Intima and Promotes Apoptosis of Cytokine-Primed Human Vascular Smooth Muscle Cells	147
Resveratrol, a Polyphenolic Compound Found in Wine, Inhibits Tissue Factor Expression in Vascular Cells	147
CXCL16/SR-PSOX Is an Interferon-γ–Regulated Chemokine and Scavenger Receptor Expressed in Atherosclerotic Lesions	147
A Proinflammatory State Is Detectable in Obese Children and Is Accompanied by Functional and Morphological Vascular Changes	147
Oxidative Stress and Vascular Disease	146
Platelet-Leukocyte Cross Talk in Whole Blood	146
Increased Immunolocalization of Paraoxonase, Clusterin, and Apolipoprotein A-I in the Human Artery Wall With the Progression of Atherosclerosis	146
Distribution of ApoA-I–Containing HDL Subpopulations in Patients With Coronary Heart Disease	146
Synergistic Effects of Fluid Shear Stress and Cyclic Circumferential Stretch on Vascular Endothelial Cell Morphology and Cytoskeleton	146
Bicuspid Aortic Valve Associated With Aortic Dilatation	146
Association of Serum Vitamin Levels, LDL Susceptibility to Oxidation, and Autoantibodies Against MDA-LDL With Carotid Atherosclerosis	146
Weight Reduction With Very-Low-Caloric Diet and Endothelial Function in Overweight Adults: Role of Plasma Glucose	146
Specific Phospholipid Oxidation Products Inhibit Ligand Activation of Toll-Like Receptors 4 and 2	146
Proteomic and Metabolomic Analyses of Atherosclerotic Vessels From Apolipoprotein E-Deficient Mice Reveal Alterations in Inflammation, Oxidative Stress, and Energy Metabolism	146
New Links Between Inflammation and Thrombosis	145
High-Density Lipoproteins Enhance Progenitor-Mediated Endothelium Repair in Mice	145
Transcriptional Profiles of Valvular and Vascular Endothelial Cells Reveal Phenotypic Differences	145
Rat Aortic MCP-1 and Its Receptor CCR2 Increase With Age and Alter Vascular Smooth Muscle Cell Function	145
Prostaglandin F ₂ -Like Compounds, F ₂ -Isoprostanes, Are Present in Increased Amounts in Human Atherosclerotic Lesions	145
Human Plasma Phospholipid Transfer Protein Increases the Antiatherogenic Potential of High Density Lipoproteins in Transgenic Mice	145
Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis	145
Simvastatin Inhibits Leukocyte–Endothelial Cell Interactions and Protects Against Inflammatory Processes in Normocholesterolemic Rats	144
Oxidized Omega-3 Fatty Acids Inhibit NF-κB Activation Via a PPARα-Dependent Pathway	144
Systematic Review on the Risk and Benefit of Different Cholesterol-Lowering Interventions	144
LDL Containing Apolipoprotein CIII Is an Independent Risk Factor for Coronary Events in Diabetic Patients	144
Role of Nuclear Factor-κB Activation in Metalloproteinase-1, -3, and -9 Secretion by Human Macrophages In Vitro and Rabbit Foam Cells Produced In Vivo	144
Common Carotid Intima-Media Thickness Predicts Occurrence of Carotid Atherosclerotic Plaques	144
Differential Activation of Mitogen-Activated Protein Kinases in Smooth Muscle Cells by Angiotensin II	144
Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Restenosis After Coronary Angioplasty	144
Characterization and Comparison of the Mode of Cell Death, Apoptosis Versus Necrosis, Induced by 7β-Hydroxycholesterol and 7-Ketocholesterol in the Cells of the Vascular Wall	144
Thrombin Activatable Fibrinolysis Inhibitor and an Antifibrinolytic Pathway	143
Oxidative Enzymopathies and Vascular Disease	143
Tetrahydrobiopterin and Cardiovascular Disease	143
Apoptosis in the Atherosclerotic Plaque	143
Specific Impairment of Human Platelet P2Y _AC ADP Receptor–Mediated Signaling by the Antiplatelet Drug Clopidogrel	143
Peroxidase Properties of Extracellular Superoxide Dismutase	143
Correlation of a Common Mutation in the Methylenetetrahydrofolate Reductase Gene With Plasma Homocysteine in Patients With Premature Coronary Artery Disease	143
PAF-Degrading Acetylhydrolase Is Preferentially Associated With Dense LDL and VHDL-1 in Human Plasma	143
Deficiency of Glutathione Peroxidase-1 Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice	143
Role of Vascular Smooth Muscle Cell Phenotypic Switching and Calcification in Aortic Aneurysm Formation	143
Oligoclonal T Cell Expansions in Atherosclerotic Lesions of Apolipoprotein E–Deficient Mice	142
Increased Autoantibody Titers Against Epitopes of Oxidized LDL in LDL Receptor–Deficient Mice With Increased Atherosclerosis	142
Ligand Specificity of LOX-1, a Novel Endothelial Receptor for Oxidized Low Density Lipoprotein	142
Oxidized LDL–Induced NF-κB Activation and Subsequent Expression of Proinflammatory Genes Are Defective in Monocyte-Derived Macrophages From CD36-Deficient Patients	142
Monocyte Chemoattractant Protein-1 Induces Proliferation and Interleukin-6 Production in Human Smooth Muscle Cells by Differential Activation of Nuclear Factor-κB and Activator Protein-1	142
Aortic Valve Calcification	142
Nitric Oxide and Endoplasmic Reticulum Stress	141
Interleukin-1 Receptor Antagonist Expression in Human Endothelial Cells and Atherosclerosis	141
Thrombin and Phenotypic Modulation of the Endothelium	141
NAD(P)H Oxidase Mediates Angiotensin II–Induced Vascular Macrophage Infiltration and Medial Hypertrophy	141
Influence of Biochemical Alterations on Arterial Stiffness in Patients With End-stage Renal Disease	141
Antibodies Against Cardiolipin and Oxidatively Modified LDL in 50-Year-Old Men Predict Myocardial Infarction	141
Adipocyte Fatty Acid–Binding Protein, aP2, Alters Late Atherosclerotic Lesion Formation in Severe Hypercholesterolemia	141
Effect of Peroxisome Proliferator–Activated Receptor-α and -γ Activators on Vascular Remodeling in Endothelin-Dependent Hypertension	141
Egr-1 is Activated in Endothelial Cells Exposed to Fluid Shear Stress and Interacts With a Novel Shear-Stress-Response Element in the PDGF A-Chain Promoter	141
IL-8 Plasma Concentrations and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women	141
Hepatic Lipase, Lipoprotein Metabolism, and Atherogenesis	140
Non-Exercise Activity Thermogenesis	140
Cytosolic Lipid Droplets Increase in Size by Microtubule-Dependent Complex Formation	140
7E3 Monoclonal Antibody Directed Against the Platelet Glycoprotein IIb/IIIa Cross-reacts With the Leukocyte Integrin Mac-1 and Blocks Adhesion to Fibrinogen and ICAM-1	140
ADP Receptor P2Y ₁₂ Is Expressed in Vascular Smooth Muscle Cells and Stimulates Contraction in Human Blood Vessels	140
Impaired Development of Atherosclerosis in Hyperlipidemic Ldlr ^−/− and ApoE ^−/− Mice Transpl	140
Thiazolidinediones and Blood Lipids in Type 2 Diabetes	139
HDL and ApoA Prevent Cell Death of Endothelial Cells Induced by Oxidized LDL	139
Adipophilin Enhances Lipid Accumulation and Prevents Lipid Efflux From THP-1 Macrophages	139
Shear Stress Inhibits H ₂ O ₂ -Induced Apoptosis of Human Endothelial Cells by Modulation of the Glutathione Redox Cycle and Nitri	139
Stromelysin-1 and Interleukin-6 Gene Promoter Polymorphisms Are Determinants of Asymptomatic Carotid Artery Atherosclerosis	139
Asymmetric Dimethylarginine Produces Vascular Lesions in Endothelial Nitric Oxide Synthase–Deficient Mice	139
Prevention of Aortic Fibrosis by Spironolactone in Spontaneously Hypertensive Rats	138
Factor V and Thrombotic Disease	138
C-Reactive Protein as a Screening Test for Cardiovascular Risk in a Multiethnic Population	138
Homocysteine-Induced Inhibition of Endothelium-Dependent Relaxation in Rabbit Aorta	138
Hydrogen Peroxide	138
Calcification of Advanced Atherosclerotic Lesions in the Innominate Arteries of ApoE-Deficient Mice	138
Functional Effects of the ABO Locus Polymorphism on Plasma Levels of von Willebrand Factor, Factor VIII, and Activated Partial Thromboplastin Time	138
The Reactive Adventitia	137
Infection and Inflammation Induce LDL Oxidation In Vivo	137
Fenofibrate Reduces Plasma Cholesteryl Ester Transfer From HDL to VLDL and Normalizes the Atherogenic, Dense LDL Profile in Combined Hyperlipidemia	137
Soluble Cell Adhesion Molecules in Hypertriglyceridemia and Potential Significance on Monocyte Adhesion	137
Decreased Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice Transplanted With Abcg1 ^−/− Bone Marrow	137
Clinical and Biochemical Results of the Metalloproteinase Inhibition with Subantimicrobial Doses of Doxycycline to Prevent Acute Coronary Syndromes (MIDAS) Pilot Trial	137
Increased Expression of Lectinlike Oxidized Low Density Lipoprotein Receptor-1 in Initial Atherosclerotic Lesions of Watanabe Heritable Hyperlipidemic Rabbits	137
Gender Differences in Experimental Aortic Aneurysm Formation	137
Osteopontin Deficiency Attenuates Atherosclerosis in Female Apolipoprotein E–Deficient Mice	137
Vitamin C and E Intake Is Associated With Increased Paraoxonase Activity	137
Enhanced T-Cell Expression of RANK Ligand in Acute Coronary Syndrome	137
Superoxide Generation in Directional Coronary Atherectomy Specimens of Patients With Angina Pectoris	137
Obesity and Oxidative Stress	136
Apolipoprotein A5 , a Newly Identified Gene That Affects Plasma Triglyceride Levels in Humans and Mice	136
Gender Difference in Postprandial Lipemia	136
Rho-Kinase Is Involved in Macrophage-Mediated Formation of Coronary Vascular Lesions in Pigs In Vivo	136
Nrf2 Gene Transfer Induces Antioxidant Enzymes and Suppresses Smooth Muscle Cell Growth In Vitro and Reduces Oxidative Stress in Rabbit Aorta In Vivo	136
ADP Receptors and Clinical Bleeding Disorders	135
Hyperlipidemia Promotes Osteoclastic Potential of Bone Marrow Cells Ex Vivo	135
Tumor Necrosis Factor-α Promotes Macrophage-Induced Vascular Smooth Muscle Cell Apoptosis by Direct and Autocrine Mechanisms	135
Hyperinsulinemia Is Associated With Increased Production Rate of Intestinal Apolipoprotein B-48–Containing Lipoproteins in Humans	135
Enhanced Fatty Streak Formation in C57BL/6J Mice by Immunization With Heat Shock Protein-65	135
No Association Between Plasma Levels of Plant Sterols and Atherosclerosis in Mice and Men	135
Peroxisome Proliferator-Activated Receptor γ Ligands Stimulate Endothelial Nitric Oxide Production Through Distinct Peroxisome Proliferator-Activated Receptor γ–Dependent Mechanisms	135
Docosahexaenoic Acid Selectively Attenuates Induction of Vascular Cell Adhesion Molecule–1 and Subsequent Monocytic Cell Adhesion to Human Endothelial Cells Stimulated by Tumor Necrosis Factor–α	135
Cholesterol Depletion Disrupts Caveolae and Differentially Impairs Agonist-Induced Arterial Contraction	134
Regression of Atherosclerosis in Female Monkeys	134
Hormone Replacement Therapy, Inflammation, and Hemostasis in Elderly Women	134
C-Reactive Protein Is Independently Associated With Fasting Insulin in Nondiabetic Women	134
FXR Deficiency Causes Reduced Atherosclerosis in Ldlr ^−/− Mice	134
Novel Candidate Genes in Unstable Areas of Human Atherosclerotic Plaques	134
Role of Lipids in Osteoporosis	133
Human Monocytes/Macrophages Release TNF-α in Response to Ox-LDL	133
Monocyte Recruitment and Neointimal Hyperplasia in Rabbits	133
Peripheral Blood Mononuclear Phagocyte Subpopulations as Cellular Markers in Hypercholesterolemia	133
NO Inhibits Cytokine-Induced iNOS Expression and NF-κB Activation by Interfering With Phosphorylation and Degradation of IκB-α	133
Circulating Leukocyte-Derived Microparticles Predict Subclinical Atherosclerosis Burden in Asymptomatic Subjects	133
Enhanced In Vivo Lipid Peroxidation at Elevated Plasma Total Homocysteine Levels	133
Relation Between Plasma Tumor Necrosis Factor-α and Insulin Sensitivity in Elderly Men With Non–Insulin-Dependent Diabetes Mellitus	133
Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human Plasma	133
Autoantibodies Against Oxidized Low Density Lipoprotein in Patients With Angiographically Verified Coronary Artery Disease	133
Macrophage ATP-Binding Cassette Transporter A1 Overexpression Inhibits Atherosclerotic Lesion Progression in Low-Density Lipoprotein Receptor Knockout Mice	133
Close Approximation of Two Platelet Factor 4 Tetramers by Charge Neutralization Forms the Antigens Recognized by HIT Antibodies	133
Tissue Factor–Factor VIIa Signaling	132
Effects of Fluvastatin on Leukocyte–Endothelial Cell Adhesion in Hypercholesterolemic Rats	132
Genetic Polymorphism of Paraoxonase and the Risk of Coronary Heart Disease	132
Nitric Oxide Protects Against Leukocyte-Endothelium Interactions in the Early Stages of Hypercholesterolemia	132
Binding and Internalization of C-Reactive Protein by Fcgamma Receptors on Human Aortic Endothelial Cells Mediates Biological Effects	132
The Sphingosine-1-Phosphate Analogue FTY720 Reduces Atherosclerosis in Apolipoprotein E–Deficient Mice	132
Plasma PAI-1 Levels Are More Strongly Related to Liver Steatosis Than to Adipose Tissue Accumulation	132
Vitamin E Inhibits Abdominal Aortic Aneurysm Formation in Angiotensin II–Infused Apolipoprotein E–Deficient Mice	132
Mass-Spectrometric Identification of a Novel Angiotensin Peptide in Human Plasma	132
Plasma Levels of Tissue Plasminogen Activator/Plasminogen Activator Inhibitor-1 Complex and von Willebrand Factor Are Significant Risk Markers for Recurrent Myocardial Infarction in the Stockholm Hear	131
Combinatorial Control of Smooth Muscle–Specific Gene Expression	131
Chondrogenesis Mediated by PP _i Depletion Promotes Spontaneous Aortic Calcification in NPP1−/− Mice	131
Identification of Soluble Forms of Lectin-Like Oxidized LDL Receptor-1	131
Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine	131
Plasma LDL and HDL Subspecies Are Heterogenous in Particle Content of Tocopherols and Oxygenated and Hydrocarbon Carotenoids	131
Bone Marrow Transplantation Reveals That Recipient AT1a Receptors Are Required to Initiate Angiotensin II–Induced Atherosclerosis and Aneurysms	131
Lipoprotein Lipase Mass and Activity in Plasma and Their Increase After Heparin Are Separate Parameters With Different Relations to Plasma Lipoproteins	131
Modulation of Lipoprotein B Binding to the LDL Receptor by Exogenous Lipids and Apolipoproteins CI, CII, CIII, and E	131
Molecular Regulation of the Bovine Endothelial Cell Nitric Oxide Synthase by Transforming Growth Factor–β ₁	131
Vascular Endothelial Growth Factor–Regulated Gene Expression in Endothelial Cells	131
Comparison of Circulating Adiponectin and Proinflammatory Markers Regarding Their Association With Metabolic Syndrome in Japanese Men	131
Factors Influencing the Ability of HDL to Inhibit Expression of Vascular Cell Adhesion Molecule-1 in Endothelial Cells	131
Peripheral Vascular Endothelial Dysfunction and Apoptosis in Old Monkeys	131
Dietary Monounsaturated Fatty Acids Promote Aortic Atherosclerosis in LDL Receptor–Null, Human ApoB100–Overexpressing Transgenic Mice	130
Peroxisome Proliferator-Activated Receptor α Agonists Increase Nitric Oxide Synthase Expression in Vascular Endothelial Cells	130
Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits	130
Sphingosine-1-Phosphate Stimulates the Functional Capacity of Progenitor Cells by Activation of the CXCR ₄ -Dependent Signaling Pathway via the S1P	130
Proatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance	130
Antibodies to Periodontal Pathogens Are Associated With Coronary Heart Disease	130
Inhibition of Triglyceride Synthesis as a Treatment Strategy for Obesity	130
Effects of Androgens on Coronary Artery Atherosclerosis and Atherosclerosis-Related Impairment of Vascular Responsiveness	129
Systemic Endothelial Dysfunction as an Early Predictor of Adverse Outcome in Heart Failure	129
Network of Vascular-Associated Dendritic Cells in Intima of Healthy Young Individuals	129
Statins Decrease Toll-Like Receptor 4 Expression and Downstream Signaling in Human CD14 ⁺ Monocytes	129
Reactive Oxygen Species Are Involved in Shear Stress-Induced Intercellular Adhesion Molecule-1 Expression in Endothelial Cells	129
Importance of a Novel Oxidative Mechanism for Elimination of Intracellular Cholesterol in Humans	129
p47phox Associates With the Cytoskeleton Through Cortactin in Human Vascular Smooth Muscle Cells	129
A Prospective Case-Control Study of Lipoprotein(a) Levels and Apo(a) Size and Risk of Coronary Heart Disease in Stanford Five-City Project Participants	129
The Relationship of Fibrinogen and Factors VII and VIII to Incident Cardiovascular Disease and Death in the Elderly	129
Curcuma longa Extract Supplementation Reduces Oxidative Stress and Attenuates Aortic Fatty Streak Development in Rabbits	129
Adiponectin Acts as an Endogenous Antithrombotic Factor	129
Uterine Spiral Artery Remodeling Involves Endothelial Apoptosis Induced by Extravillous Trophoblasts Through Fas/FasL Interactions	129
Role of ADAMTS-1 in Atherosclerosis	129
The Molecular Basis of Lecithin:Cholesterol Acyltransferase Deficiency Syndromes	129
Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease	129
What Is So Special About Apolipoprotein AI in Reverse Cholesterol Transport?	128
Infection and Atherosclerosis	128
Interleukin-6 −174G>C Polymorphism and Risk of Coronary Heart Disease in West of Scotland Coronary Prevention Study (WOSCOPS)	128
The Role of Triglyceride-Rich Lipoprotein Families in the Progression of Atherosclerotic Lesions as Determined by Sequential Coronary Angiography From a Controlled Clinical Trial	128
Association Between 5-Lipoxygenase Expression and Plaque Instability in Humans	128
Endotoxin and Cytokines Increase Hepatic Sphingolipid Biosynthesis and Produce Lipoproteins Enriched in Ceramides and Sphingomyelin	128
Venous Thrombosis–Associated Inflammation and Attenuation With Neutralizing Antibodies to Cytokines and Adhesion Molecules	128
Tissue-Engineered Blood Vessels	127
Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR–α Activators	127
Mechanisms of Renal Structural Alterations in Combined Hypercholesterolemia and Renal Artery Stenosis	127
Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic Syndrome	127
TWEAK Is an Endothelial Cell Growth and Chemotactic Factor That Also Potentiates FGF-2 and VEGF-A Mitogenic Activity	127
Common Variants in the Promoter of the Hepatic Lipase Gene Are Associated With Lower Levels of Hepatic Lipase Activity, Buoyant LDL, and Higher HDL ₂ Cholesterol	127
Differential Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Sensitivity to Activated Protein C Among Postmenopausal Women	127
No Effect of Consumption of Green and Black Tea on Plasma Lipid and Antioxidant Levels and on LDL Oxidation in Smokers	127
Functional Interplay Between Angiotensin II and Nitric Oxide	126
Isolation of “Side Population” Progenitor Cells From Healthy Arteries of Adult Mice	126
Increased LDL Cholesterol and Atherosclerosis in LDL Receptor–Deficient Mice With Attenuated Expression of Scavenger Receptor B1	126
Regulation of Plasma High-Density Lipoprotein Levels by the ABCA1 Transporter and the Emerging Role of High-Density Lipoprotein in the Treatment of Cardiovascular Disease	126
Advanced Oxidation Protein Products Accelerate Atherosclerosis Through Promoting Oxidative Stress and Inflammation	126
New Functional Promoter Polymorphism, CETP/−629, in Cholesteryl Ester Transfer Protein (CETP) Gene Related to CETP Mass and High Density Lipoprotein Cholesterol Levels	126
Value of HDL Cholesterol, Apolipoprotein A-I, Lipoprotein A-I, and Lipoprotein A-I/A-II in Prediction of Coronary Heart Disease	126
Angiotensin II Attenuates Endothelium-Dependent Responses in the Cerebral Microcirculation Through Nox-2–Derived Radicals	125
Human Paraoxonase-1 Overexpression Inhibits Atherosclerosis in a Mouse Model of Metabolic Syndrome	125
Macrophages Isolated From Human Atherosclerotic Plaques Produce IL-8, and Oxysterols May Have a Regulatory Function for IL-8 Production	125
C-Reactive Protein–Induced In Vitro Endothelial Cell Activation Is an Artefact Caused by Azide and Lipopolysaccharide	125
Hypoadiponectinemia Is Associated With Ischemic Cerebrovascular Disease	125
Flow-Mediated Dilatation Is Impaired by a High–Saturated Fat Diet but Not by a High-Carbohydrate Diet	125
Adipocyte Differentiation-Related Protein Promotes Fatty Acid Storage in Cytosolic Triglycerides and Inhibits Secretion of Very Low–Density Lipoproteins	125
Induction of Atherosclerosis by Low-Fat, Semisynthetic Diets in LDL Receptor–Deficient C57BL/6J and FVB/NJ Mice	125
Connective Tissue Growth Factor	124
Vascular Injury Induces Expression of Periostin	124
Minimally Oxidized Low-Density Lipoprotein Increases Expression of Scavenger Receptor A, CD36, and Macrosialin in Resident Mouse Peritoneal Macrophages	124
Hypoxia/Hypoxemia-Induced Activation of the Procoagulant Pathways and the Pathogenesis of Ischemia-Associated Thrombosis	124
Iron Overload Augments the Development of Atherosclerotic Lesions in Rabbits	124
Cortical Microvascular Remodeling in the Stenotic Kidney	124
Hypoxia Converts Human Macrophages Into Triglyceride-Loaded Foam Cells	124
Childhood C-Reactive Protein in Predicting CRP and Carotid Intima-Media Thickness in Adulthood	124
Heme Oxygenase-1 Gene Promoter Polymorphism Is Associated With Coronary Artery Disease in Japanese Patients With Coronary Risk Factors	124
Electron Spin Resonance Detection of Hydrogen Peroxide as an Endothelium-Derived Hyperpolarizing Factor in Porcine Coronary Microvessels	124
C-Reactive Protein, Fibrin D-Dimer, and Incident Ischemic Heart Disease in the Speedwell Study	124
Increase of Vitamin E Content in LDL and Reduction of Atherosclerosis in Cholesterol-Fed Rabbits by a Water-Soluble Antioxidant-Rich Fraction of Salvia miltiorrhiza	124
Associations of HDL ₂ and HDL ₃ Subfractions With Ischemic Heart Disease in Men	124
Porphyromonas gingivalis Bacteremia Induces Coronary and Aortic Atherosclerosis in Normocholesterolemic and Hypercholesterolemic Pigs	124
Development of an Animal Model for Spontaneous Myocardial Infarction (WHHLMI Rabbit)	123
Plasminogen Activator Expression in Human Atherosclerotic Lesions	123
Relationships of Cerebral MRI Findings to Ultrasonographic Carotid Atherosclerosis in Older Adults	123
Repetitive Fluctuations in Blood Glucose Enhance Monocyte Adhesion to the Endothelium of Rat Thoracic Aorta	123
Bone Marrow–Derived Monocyte Chemoattractant Protein-1 Receptor CCR2 Is Critical in Angiotensin II–Induced Acceleration of Atherosclerosis and Aneurysm Formation in Hypercholesterolemic Mice	123
CD36, a Novel Receptor for Oxidized Low-Density Lipoproteins, Is Highly Expressed on Lipid-Laden Macrophages in Human Atherosclerotic Aorta	123
Arterial Compliance in Obese Subjects Is Improved With Dietary Plant n-3 Fatty Acid From Flaxseed Oil Despite Increased LDL Oxidizability	123
Polymorphisms of the Interleukin-1β Gene Affect the Risk of Myocardial Infarction and Ischemic Stroke at Young Age and the Response of Mononuclear Cells to Stimulation In Vitro	123
Genetic Determinants of Arterial Thrombosis	122
Detection, Quantification, and Characterization of Potentially Atherogenic Triglyceride-Rich Remnant Lipoproteins	122
Ultrasound and Lipoproteins as Predictors of Lipid-Rich, Rupture-Prone Plaques in the Carotid Artery	122
Stem Cell Transplantation Reveals That Absence of Macrophage CD36 Is Protective Against Atherosclerosis	122
Probucol Inhibits ABCA1-Mediated Cellular Lipid Efflux	122
Oxidized Low Density Lipoproteins in Patients With Transplant-Associated Coronary Artery Disease	122
Decoding Transcriptional Programs Regulated by PPARs and LXRs in the Macrophage	122
Lipoprotein Subclasses in the Monitored Atherosclerosis Regression Study (MARS)	122
Crystallization of Free Cholesterol in Model Macrophage Foam Cells	122
Local Hypomethylation in Atherosclerosis Found in Rabbit ec-sod Gene	122
Human Serum Paraoxonase 1 Decreases Macrophage Cholesterol Biosynthesis	122
Impact of Short-Term Administration of High-Density Lipoproteins and Atorvastatin on Atherosclerosis in Rabbits	122
Cross-Reactive B-Cell Epitopes of Microbial and Human Heat Shock Protein 60/65 in Atherosclerosis	122
Long Pentraxin PTX3 Upregulates Tissue Factor Expression in Human Endothelial Cells	122
Effects of Intracellular Free Cholesterol Accumulation on Macrophage Viability	122
Purification, Properties, Sequencing, and Cloning of a Lipoprotein-Associated, Serine-Dependent Phospholipase Involved in the Oxidative Modification of Low-Density Lipoproteins	122
Haptoglobin Genotype Is a Determinant of Iron, Lipid Peroxidation, and Macrophage Accumulation in the Atherosclerotic Plaque	122
White Blood Cell Count and the Risk of Coronary Heart Disease and All-Cause Mortality in Elderly Men	121
TNF-α Contributes to Endothelial Dysfunction in Ischemia/Reperfusion Injury	121
The Effect of Supplementation With Omega-3 Fatty Acids on Soluble Markers of Endothelial Function in Patients With Coronary Heart Disease	121
Diabetes Mellitus	121
Very-Low-Density Lipoprotein Response Element in the Promoter Region of the Human Plasminogen Activator Inhibitor-1 Gene Implicated in the Impaired Fibrinolysis of Hypertriglyceridemia	121
Mouse Macrophage Paraoxonase 2 Activity Is Increased Whereas Cellular Paraoxonase 3 Activity Is Decreased Under Oxidative Stress	121
Parathyroid Hormone–Related Peptide as a Local Regulator of Vascular Calcification	121
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines	121
High Levels of Lp(a) With a Small Apo(a) Isoform Are Associated With Coronary Artery Disease in African American and White Men	121
Thrombin Activates Factor XI on Activated Platelets in the Absence of Factor XII	120
LOX-1, an Oxidized LDL Endothelial Receptor, Induces CD40/CD40L Signaling in Human Coronary Artery Endothelial Cells	120
Lipoprotein Lipase S447X	120
Leukocyte-Derived Interleukin 10 Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice	120
Metabolic Basis of Hypotriglyceridemic Effects of Insulin in Normal Men	120
Two Alleles of the Human Paraoxonase Gene Produce Different Amounts of mRNA	120
HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum	120
Carotid Plaque Composition Differs Between Ethno-Racial Groups	120
Increased Blood Flow Induces Regression of Intimal Hyperplasia	119
Adiponectin and Coronary Heart Disease: The Strong Heart Study	119
Human Urotensin II Is a Novel Activator of NADPH Oxidase in Human Pulmonary Artery Smooth Muscle Cells	119
The Gln-Arg192 Polymorphism of Human Paraoxonase Gene Is Not Associated With Coronary Artery Disease in Italian Patients	119
Perivascular Adipose Tissue and Mesenteric Vascular Function in Spontaneously Hypertensive Rats	119
Linked Chromosome 16q13 Chemokines, Macrophage-Derived Chemokine, Fractalkine, and Thymus- and Activation-Regulated Chemokine, Are Expressed in Human Atherosclerotic Lesions	119
Oxidized LDL Regulates Vascular Endothelial Growth Factor Expression in Human Macrophages and Endothelial Cells Through Activation of Peroxisome Proliferator–Activated Receptor-γ	119
Adrenomedullin	118
Novel Vascular Biology of Third-Generation L-Type Calcium Channel Antagonists	118
Regulation of Monocyte CD36 and Thrombospondin-1 Expression by Soluble Mediators	118
Angiotensin II Type 1 Receptor Antagonism Improves Hypercholesterolemia-Associated Endothelial Dysfunction	118
Lymphocyte Populations in Atherosclerotic Lesions of ApoE −/− and LDL Receptor −/− Mice	118
Chemokine Receptor CCR2 Expression and Monocyte Chemoattractant Protein-1–Mediated Chemotaxis in Human Monocytes	118
Can Exercise Training With Weight Loss Lower Serum C-Reactive Protein Levels?	118
Androgen Deprivation Is Associated With Enhanced Endothelium-Dependent Dilatation in Adult Men	118
Carbon Monoxide Protects Against Cardiac Ischemia—Reperfusion Injury In Vivo via MAPK and Akt—eNOS Pathways	118
Adipocyte Fatty Acid–Binding Protein Expression and Lipid Accumulation Are Increased During Activation of Murine Macrophages by Toll-Like Receptor Agonists	118
Change in α ₁ HDL Concentration Predicts Progression in Coronary Artery Stenosis	118
Endothelial Dysfunction and Low-Grade Inflammation Explain Much of the Excess Cardiovascular Mortality in Individuals With Type 2 Diabetes	118
D-4F and Statins Synergize to Render HDL Antiinflammatory in Mice and Monkeys and Cause Lesion Regression in Old Apolipoprotein E–Null Mice	118
Atherosclerotic Disease in Marked Hyperalphalipoproteinemia	118
Matrix Metalloproteinase Inhibition Attenuates Aortic Calcification	117
Mineral Exploration: Search for the Mechanism of Vascular Calcification and Beyond	117
Antagonistic Effects of 17β-Estradiol, Progesterone, and Testosterone on Ca ²⁺ Entry Mechanisms of Coronary Vasoconstriction	117
Lack of Interleukin-1 Receptor Antagonist Modulates Plaque Composition in Apolipoprotein E–Deficient Mice	117
Cosupplementation With Coenzyme Q Prevents the Prooxidant Effect of α-Tocopherol and Increases the Resistance of LDL to Transition Metal–Dependent Oxidation Initiation	117
Simvastatin Modulates Expression of the PON1 Gene and Increases Serum Paraoxonase	117
Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events	117
Effects of Long-Term Daily Low-Dose Supplementation With Antioxidant Vitamins and Minerals on Structure and Function of Large Arteries	117
Inflammatory Mediators and Cell Adhesion Molecules as Indicators of Severity of Atherosclerosis	117
Smooth Muscle Cell Phenotypic Diversity	117
Inhibition of Neointima Formation by a Novel Drug-Eluting Stent System That Allows for Dose-Adjustable, Multiple, and On-Site Stent Coating	117
Detection of Osteopontin in Calcified Human Aortic Valves	116
Contrary Effects of Lightly and Strongly Oxidized LDL With Potent Promotion of Growth Versus Apoptosis on Arterial Smooth Muscle Cells, Macrophages, and Fibroblasts	116
Role of Mitochondrial Oxidant Generation in Endothelial Cell Responses to Hypoxia	116
Heterogeneity of Smooth Muscle Cell Populations Cultured From Pig Coronary Artery	116
Impaired Superoxide Production Due to a Deficiency in Phagocyte NADPH Oxidase Fails to Inhibit Atherosclerosis in Mice	116
Improvement of Collateral Perfusion and Regional Function by Implantation of Peripheral Blood Mononuclear Cells Into Ischemic Hibernating Myocardium	116
Abdominal Aortic Aneurysm Rupture Is Associated With Increased Medial Neovascularization and Overexpression of Proangiogenic Cytokines	116
Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates	116
Localization of Nonpancreatic Secretory Phospholipase A ₂ in Normal and Atherosclerotic Arteries	116
Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal Women	116
Endothelial Nitric Oxide Synthase Activation by Tumor Necrosis Factor α Through Neutral Sphingomyelinase 2, Sphingosine Kinase 1, and Sphingosine 1 Phosphate Receptors	116
Plasma Thrombin-Activatable Fibrinolysis Inhibitor Antigen Concentration and Genotype in Relation to Myocardial Infarction in the North and South of Europe	116
Signaling in Leukocyte Transendothelial Migration	115
Regression or Progression	115
ABCA1-Deficient Mice	115
Simvastatin Promotes Atherosclerotic Plaque Stability in ApoE-Deficient Mice Independently of Lipid Lowering	115
Adoptive Transfer of CD4 ⁺ T Cells Reactive to Modified Low-Density Lipoprotein Aggravates Atherosclerosis	115
Rapid Perfusion and Network Remodeling in a Microvascular Construct After Implantation	115
New Insights Into the Role of Lipoprotein(a)-Associated Lipoprotein-Associated Phospholipase A ₂ in Atherosclerosis and Cardiovascular Disease	115
Number and Adhesive Properties of Circulating Endothelial Progenitor Cells in Patients With In-Stent Restenosis	115
Critical Role of Rho-Kinase and MEK/ERK Pathways for Angiotensin II–Induced Plasminogen Activator Inhibitor Type-1 Gene Expression	115
Expression of ACAT-1 Protein in Human Atherosclerotic Lesions and Cultured Human Monocytes-Macrophages	115
Epidemiology of Vascular Dementia	115
Trichostatin A Exacerbates Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice	115
Analysis of Coagulation Cascade and Endothelial Cell Activation During Inhibition of Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Pathway in Cancer Patients	115
Mouse Model of Femoral Artery Denudation Injury Associated With the Rapid Accumulation of Adhesion Molecules on the Luminal Surface and Recruitment of Neutrophils	115
Selective Blockade of the Intermediate-Conductance Ca ²⁺ -Activated K ⁺ Channel Suppresses Proliferation of Microvascular and Macr	115
Cholesteryl Ester Transfer Protein *Taq* I B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Hea	115
Molecular Basis of Platelet Granule Secretion	114
Endothelial Nitric Oxide Synthase	114
MRI and Characterization of Atherosclerotic Plaque	114
Uncoupling of Endothelial Nitric Oxidase Synthase by Hypochlorous Acid	114
Controlled Trial of α-Tocopherol and β-Carotene Supplements on Stroke Incidence and Mortality in Male Smokers	114
Type 2 Diabetic Mice Have Increased Arteriolar Tone and Blood Pressure	114
Reactive Oxygen Species Mediate Endothelium-Dependent Relaxations in Tetrahydrobiopterin-Deficient Mice	114
Risk of Venous Thromboembolism and Clinical Manifestations in Carriers of Antithrombin, Protein C, Protein S Deficiency, or Activated Protein C Resistance	114
Regulation of Functions of Vascular Wall Cells by Tissue Factor Pathway Inhibitor	113
Interaction Between the G20210A Mutation of the Prothrombin Gene and Oral Contraceptive Use in Deep Vein Thrombosis	113
Protection of Endothelial Survival by Peroxisome Proliferator-Activated Receptor-δ Mediated 14-3-3 Upregulation	113
Vascular Dysfunction and Reduced Circulating Endothelial Progenitor Cells in Young Healthy UK South Asian Men	113
Applications of Nanotechnology to Atherosclerosis, Thrombosis, and Vascular Biology	112
Physiological Increments in Plasma Homocysteine Induce Vascular Endothelial Dysfunction in Normal Human Subjects	112
Decreased Serum Testosterone in Men With Acute Ischemic Stroke	112
Tumor Necrosis Factor-α Activates Smooth Muscle Cell Migration in Culture and Is Expressed in the Balloon-Injured Rat Aorta	112
Oxidized Phospholipids Trigger Atherogenic Inflammation in Murine Arteries	112
Influence of Folic Acid on Postprandial Endothelial Dysfunction	112
Adaptive Remodeling of Internal Elastic Lamina and Endothelial Lining During Flow-Induced Arterial Enlargement	112
Coronary and Aortic Calcification Among Women 8 Years After Menopause and Their Premenopausal Risk Factors	112
Reduced Atherosclerotic Lesions in Mice Deficient for Total or Macrophage-Specific Expression of Scavenger Receptor-A	112
Clinical Studies and Thrombin Generation in Patients Homozygous or Heterozygous for the G20210A Mutation in the Prothrombin Gene	112
Ginkgo biloba Extract Inhibits Tumor Necrosis Factor-α–Induced Reactive Oxygen Species Generation, Transcription Factor Activation, and Cell Adhesion Molecule Expression in Human Ao	112
ICAM-1 Deficiency Reduces Atherosclerotic Lesions in Double-Knockout Mice (ApoE ⁻ ^/− /ICAM-1 ⁻ ^/−	112
Suppression of Rage as a Basis of Simvastatin-Dependent Plaque Stabilization in Type 2 Diabetes	112
Increased Concentrations of C-Reactive Protein and IL-6 but not IL-18 Are Independently Associated With Incident Coronary Events in Middle-Aged Men and Women	112
The Natural Course of Atherosclerosis	111
Cellular Senescence After Single and Repeated Balloon Catheter Denudations of Rabbit Carotid Arteries	111
Cerebrovascular Nitrosative Stress Mediates Neurovascular and Endothelial Dysfunction Induced by Angiotensin II	111
Activation of Mitogen-Activated Protein Kinases (ERK/JNK) and AP-1 Transcription Factor in Rat Carotid Arteries After Balloon Injury	111
Statins Inhibit Synthesis of an Oxysterol Ligand for the Liver X Receptor in Human Macrophages With Consequences for Cholesterol Flux	111
Serum Antibody Levels to Actinobacillus actinomycetemcomitans Predict the Risk for Coronary Heart Disease	111
Effect of Immune Deficiency on Lipoproteins and Atherosclerosis in Male Apolipoprotein E–Deficient Mice	111
Correlation Between Flow-Mediated Vasodilatation of the Brachial Artery and Intima-Media Thickness in the Carotid Artery in Men	111
A New Promoter Polymorphism in the Gene of Lipopolysaccharide Receptor CD14 Is Associated With Expired Myocardial Infarction in Patients With Low Atherosclerotic Risk Profile	111
Differentiation of Smooth Muscle Cells in Human Blood Vessels as Defined by Smoothelin, a Novel Marker for the Contractile Phenotype	111
Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory Cells	111
The Roles of Proteinase-Activated Receptors in the Vascular Physiology and Pathophysiology	110
Statin Therapy in Acute Coronary Syndromes	110
Elastogenesis in Human Arterial Disease	110
Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis	110
Extracellular Proteases in Atherosclerosis and Restenosis	110
Imatinib Attenuates Diabetes-Associated Atherosclerosis	110
Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory Biomarkers	110
Megakaryocyte Ploidy and Platelet Changes in Human Diabetes and Atherosclerosis	110
Oxidized LDLs Induce Massive Apoptosis of Cultured Human Endothelial Cells Through a Calcium-Dependent Pathway	110
Immunohistochemical Demonstration of Enzymatically Modified Human LDL and Its Colocalization With the Terminal Complement Complex in the Early Atherosclerotic Lesion	110
Fibrin and Activated Platelets Cooperatively Guide Stem Cells to a Vascular Injury and Promote Differentiation Towards an Endothelial Cell Phenotype	110
Hyperhomocystinemia Impairs Endothelial Function and eNOS Activity via PKC Activation	110
Decreased Protection by HDL From Poorly Controlled Type 2 Diabetic Subjects Against LDL Oxidation May Be Due to the Abnormal Composition of HDL	110
Anti–MCP-1 Gene Therapy Inhibits Vascular Smooth Muscle Cells Proliferation and Attenuates Vein Graft Thickening Both In Vitro and In Vivo	110
Redox Modulation of Vascular Tone	109
α-Tocopherol Decreases Interleukin-1β Release From Activated Human Monocytes by Inhibition of 5-Lipoxygenase	109
Upregulation of Prostacyclin Synthesis–Related Gene Expression by Shear Stress in Vascular Endothelial Cells	109
Platelet Rebound Effect of Alcohol Withdrawal and Wine Drinking in Rats	109
Depletion of Natural Killer Cell Function Decreases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice	109
Increased Monocyte Adhesion to Aortic Endothelium in Rats With Hyperhomocysteinemia	109
Oxidized Phospholipid-Induced Endothelial Cell/Monocyte Interaction Is Mediated by a cAMP-Dependent R-Ras/PI3-Kinase Pathway	109
Endogenous Nitric Oxide Synthesis Inhibitor Asymmetric Dimethyl l -Arginine Accelerates Endothelial Cell Senescence	109
Antioxidative and Antiatherosclerotic Effects of Human Apolipoprotein A-IV in Apolipoprotein E–Deficient Mice	109
Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells	109
New Insights Into the Differentiation of Megakaryocytes From Hematopoietic Progenitors	109
A ¹⁹² Arg Variant of the Human Paraoxonase (HUMPONA) Gene Polymorphism Is Associated With an Increased Risk for Coronary Artery Diseas	109
Association of High Coronary Heart Disease Risk Status With Circulating Oxidized LDL in the Well-Functioning Elderly	109
Common C-to-T Substitution at Position −480 of the Hepatic Lipase Promoter Associated With a Lowered Lipase Activity in Coronary Artery Disease Patients	109
Vitamin Supplementation Reduces Blood Homocysteine Levels	109
α-Lipoic Acid Prevents Endothelial Dysfunction in Obese Rats via Activation of AMP-Activated Protein Kinase	109
Noncollagenous Bone Matrix Proteins, Calcification, and Thrombosis in Carotid Artery Atherosclerosis	108
Immunologic Detection and Measurement of Hypochlorite-Modified LDL With Specific Monoclonal Antibodies	108
Phenotypic Heterogeneity of Rat Arterial Smooth Muscle Cell Clones	108
High Plasma Phospholipid Transfer Protein Levels as a Risk Factor for Coronary Artery Disease	108
Quantification of Postprandial Triglyceride-Rich Lipoproteins in Healthy Men by Retinyl Ester Labeling and Simultaneous Measurement of Apolipoproteins B-48 and B-100	108
Asymmetric Dimethylarginine Predicts Major Adverse Cardiovascular Events in Patients With Advanced Peripheral Artery Disease	108
Gene Expression Phenotypes of Atherosclerosis	108
A Common Mutation in the Methylenetetrahydrofolate Reductase Gene (C677T) Increases the Risk for Deep-Vein Thrombosis in Patients With Mutant Factor V (Factor V:Q ⁵⁰⁶	108
Insulin-Like Growth Factor Binding Protein-4 Protease Produced by Smooth Muscle Cells Increases in the Coronary Artery After Angioplasty	108
Sphingosine-1-Phosphate Prevents Tumor Necrosis Factor-α–Mediated Monocyte Adhesion to Aortic Endothelium in Mice	108
Cytoskeletal Effects of Rho-Like Small Guanine Nucleotide–Binding Proteins in the Vascular System	107
Regulation of Fibrinolysis by Thrombin Activatable Fibrinolysis Inhibitor, an Unstable Carboxypeptidase B That Unites the Pathways of Coagulation and Fibrinolysis	107
Acute Effects of Intravenous Infusion of ApoA1/Phosphatidylcholine Discs on Plasma Lipoproteins in Humans	107
Plasma Viscosity and the Risk of Coronary Heart Disease	107
Dimorphism in the P2Y1 ADP Receptor Gene Is Associated With Increased Platelet Activation Response to ADP	107
Biologically Active CD40 Ligand Is Elevated in Sickle Cell Anemia	107
Extracellular Matrix Modulates Macrophage Functions Characteristic to Atheroma	107
Clopidogrel Improves Systemic Endothelial Nitric Oxide Bioavailability in Patients With Coronary Artery Disease	107
Lipoprotein Lipase Gene Variation Is Associated With a Paternal History of Premature Coronary Artery Disease and Fasting and Postprandial Plasma Triglycerides	107
Curcumin Inhibits Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cell Function and Injury-Induced Neointima Formation	107
Correlation of Vasa Vasorum Neovascularization and Plaque Progression in Aortas of Apolipoprotein E ^−/− /Low-Density Lipoprotein ^−/−	107
A Novel Loss of Function Mutation of PCSK9 Gene in White Subjects With Low-Plasma Low-Density Lipoprotein Cholesterol	107
Improving Prediction of Ischemic Cardiovascular Disease in the General Population Using Apolipoprotein B	106
Diabetes and Progression of Carotid Atherosclerosis	106
Mechanism of Endothelial Dysfunction in Apolipoprotein E–Deficient Mice	106
Association Between the PPARA L162V Polymorphism and Plasma Lipid Levels	106
Atherosclerotic Plaque Rupture	106
Leukotriene B ₄ Strongly Increases Monocyte Chemoattractant Protein-1 in Human Monocytes	106
The Heterozygous 20210 G/A Prothrombin Genotype Is Associated With Early Venous Thrombosis in Inherited Thrombophilias and Is Not Increased in Frequency in Artery Disease	106
Omega-3 Fatty Acids in Adipose Tissue and Risk of Myocardial Infarction	106
High-Density Lipoproteins: A New Potential Therapeutic Target for the Prevention of Cardiovascular Disease	106
Physical Training Improves Flow-Mediated Dilation in Patients With the Polymetabolic Syndrome	106
Genetic and Environmental Determinants of Fibrin Structure and Function	105
In Vivo Imaging of Thrombin Activity in Experimental Thrombi With Thrombin-Sensitive Near-Infrared Molecular Probe	105
C-Reactive Protein Alters Antioxidant Defenses and Promotes Apoptosis in Endothelial Progenitor Cells	105
Dyslipidemia and Vascular Dysfunction in Diabetic Pigs Fed an Atherogenic Diet	105
IQGAP1 Regulates Reactive Oxygen Species–Dependent Endothelial Cell Migration Through Interacting With Nox2	105
Prospective Evaluation of the Risk Conferred by Factor V Leiden and Thermolabile Methylenetetrahydrofolate Reductase Polymorphisms in Pregnancy	105
In Situ Localization and Quantification of mRNA for 92-kD Type IV Collagenase and Its Inhibitor in Aneurysmal, Occlusive, and Normal Aorta	105
Apolipoprotein A-V Deficiency Results in Marked Hypertriglyceridemia Attributable to Decreased Lipolysis of Triglyceride-Rich Lipoproteins and Removal of Their Remnants	105
Simvastatin Reduces the Expression of Adhesion Molecules in Circulating Monocytes From Hypercholesterolemic Patients	105
Identification of Soluble Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (sTWEAK) as a Possible Biomarker of Subclinical Atherosclerosis	105
Atherosclerosis in Chronic Kidney Disease	105
“Tall Oil”–Derived Phytosterols Reduce Atherosclerosis in ApoE-Deficient Mice	104
Coagulation Factor VII and the Risk of Coronary Heart Disease in Healthy Men	104
Adiponectin Is an Important Determinant of ApoA-I Catabolism	104
Simvastatin Preserves Coronary Endothelial Function in Hypercholesterolemia in the Absence of Lipid Lowering	104
Group V Secretory Phospholipase A ₂ Promotes Atherosclerosis	104
Effects of Rosiglitazone on Lipids, Adipokines, and Inflammatory Markers in Nondiabetic Patients With Low High-Density Lipoprotein Cholesterol and Metabolic Syndrome	104
Deep Vein Thrombosis Resolution Is Modulated by Monocyte CXCR2-Mediated Activity in a Mouse Model	104
Platelet Activation Induces Cell-Surface Immunoreactive Tissue Factor Expression, Which Is Modulated Differently by Antiplatelet Drugs	104
Hyperhomocysteinemia and Oxidative Stress	103
Vascular Myofibroblasts	103
Hepatic and Extrahepatic Scavenger Receptors	103
Involvement of the Antimicrobial Peptide LL-37 in Human Atherosclerosis	103
Deficiency of Niemann-Pick C1 Like 1 Prevents Atherosclerosis in ApoE ^−/− Mice	103
Induction of Macrophage VEGF in Response to Oxidized LDL and VEGF Accumulation in Human Atherosclerotic Lesions	103
Connective Tissue Growth Factor Is Overexpressed in Complicated Atherosclerotic Plaques and Induces Mononuclear Cell Chemotaxis In Vitro	103
15d-Prostaglandin J ₂ Protects Brain From Ischemia-Reperfusion Injury	103
Differentiation, Dedifferentiation, and Apoptosis of Smooth Muscle Cells During the Development of the Human Ductus Arteriosus	103
Factor V Leiden, Hormone Replacement Therapy, and Risk of Venous Thromboembolic Events in Women With Coronary Disease	103
Vascular Superoxide Dismutase Deficiency Impairs Endothelial Vasodilator Function Through Direct Inactivation of Nitric Oxide and Increased Lipid Peroxidation	103
Human Monocyte Heterogeneity as Revealed by High-Dimensional Mass Cytometry	103
Enhanced Expression of the Homeostatic Chemokines CCL19 and CCL21 in Clinical and Experimental Atherosclerosis	103
The Natural Course of Atherosclerosis	102
Soluble Elastin Fragments in Serum Are Elevated in Acute Aortic Dissection	102
Association Between Osteopontin and Human Abdominal Aortic Aneurysm	102
Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men	102
RAGE Axis	102
Intracellular and Surface Distribution of Monocyte Tissue Factor	102
Hyperlipidemia and Atherosclerotic Lesion Development in LDL Receptor–Deficient Mice Fed Defined Semipurified Diets With and Without Cholate	102
Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population	102
Effects of Peroxisome Proliferator-Activated Receptor Ligands, Bezafibrate and Fenofibrate, on Adiponectin Level	102
Role of Group II Secretory Phospholipase A ₂ in Atherosclerosis	102
Apolipoprotein E Recycling	101
Oxidized LDL Stimulates Mitogen-Activated Protein Kinases in Smooth Muscle Cells and Macrophages	101
Fibronectin Expression and Aortic Wall Elastic Modulus in Spontaneously Hypertensive Rats	101
A Common Functional Polymorphism in the Promoter Region of the Microsomal Triglyceride Transfer Protein Gene Influences Plasma LDL Levels	101
Blood Pressure Increase and Incidence of Hypertension in Relation to Inflammation-Sensitive Plasma Proteins	101
Ultrasound Morphology Classification of the Arterial Wall and Cardiovascular Events in a 6-Year Follow-up Study	101
PAI-1 Plasma Levels in a General Population Without Clinical Evidence of Atherosclerosis	101
Increased Ratio of CD31 ⁺ /CD42 ⁻ Microparticles to Endothelial Progenitors as a Novel Marker of Atherosclerosis in Hypercholester	101
Familial Resemblance of Plasma Lipids, Lipoproteins and Postheparin Lipoprotein and Hepatic Lipases in the HERITAGE Family Study	101
Vascular Implications of the Krüppel-Like Family of Transcription Factors	100
Regional Body Composition Changes Exhibit Opposing Effects on Coronary Heart Disease Risk Factors	100
C-Reactive Protein Decreases Tissue Plasminogen Activator Activity in Human Aortic Endothelial Cells	100
Hepatocyte Growth Factor/Scatter Factor Can Induce Angiogenesis Independently of Vascular Endothelial Growth Factor	100
Advanced Glycosylation End Products Might Promote Atherosclerosis Through Inducing the Immune Maturation of Dendritic Cells	100
Progression of Carotid Intima-Media Thickness and Plasma Antioxidants: The Los Angeles Atherosclerosis Study	100
Prognostic Value of Abnormal Vasoreactivity of Epicardial Coronary Arteries to Sympathetic Stimulation in Patients With Normal Coronary Angiograms	100
PAR-1 Activation on Human Late Endothelial Progenitor Cells Enhances Angiogenesis In Vitro With Upregulation of the SDF-1/CXCR4 System	100
Caveolin-1 Is Essential for Activation of Rac1 and NAD(P)H Oxidase After Angiotensin II Type 1 Receptor Stimulation in Vascular Smooth Muscle Cells	100
Adrenomedullin/Cyclic AMP Pathway Induces Notch Activation and Differentiation of Arterial Endothelial Cells From Vascular Progenitors	100
Sex Differences in Visceral Fat Lipolysis and Metabolic Complications of Obesity	99
Effect of Fluid Flow on Smooth Muscle Cells in a 3-Dimensional Collagen Gel Model	99
CD40 Ligand Influences Platelet Release of Reactive Oxygen Intermediates	99
Niacin Accelerates Intracellular ApoB Degradation by Inhibiting Triacylglycerol Synthesis in Human Hepatoblastoma (HepG2) Cells	99
Heparin Inhibition of Endothelial Cell Proliferation and Organization Is Dependent on Molecular Weight	99
eNOS Gene Transfer Inhibits Smooth Muscle Cell Migration and MMP-2 and MMP-9 Activity	99
Intimal Retention of Cholesterol Derived From Apolipoprotein B100– and Apolipoprotein B48–Containing Lipoproteins in Carotid Arteries of Watanabe Heritable Hyperlipidemic Rabbits	99
Transcriptional and Posttranscriptional Regulation of Cyclooxygenase-2 Expression by Fluid Shear Stress in Vascular Endothelial Cells	99
Shear Stress as an Inhibitor of Vascular Smooth Muscle Cell Proliferation	99
Changes in Ubiquitin Proteasome Pathway Gene Expression in Skeletal Muscle With Exercise and Statins	99
Differential Involvement of the P2Y ₁ and P2Y ₁₂ Receptors in Platelet Procoagulant Activity	99
Phenotypic Modulation of Intima and Media Smooth Muscle Cells in Fatal Cases of Coronary Artery Lesion	99
Inhibition of Tissue Factor Gene Activation in Cultured Endothelial Cells by Curcumin	99
Genome-Wide Linkage Analysis of the Acute Coronary Syndrome Suggests a Locus on Chromosome 2	99
Increased Circulating Malondialdehyde-Modified LDL Levels in Patients With Coronary Artery Diseases and Their Association With Peak Sizes of LDL Particles	99
Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice	99
Regulation of Transport of the Angiotensin AT2 Receptor by a Novel Membrane-Associated Golgi Protein	99
Sca-1 ⁺ Progenitors Derived From Embryonic Stem Cells Differentiate Into Endothelial Cells Capable of Vascular Repair After Arterial Injury	99
Association of Postprandial Triglyceride and Retinyl Palmitate Responses With Asymptomatic Carotid Artery Atherosclerosis in Middle-aged Men and Women	99
Effect of Oral and Transdermal Estrogen Replacement Therapy on Hemostatic Variables Associated With Venous Thrombosis	99
−455G/A Polymorphism of the β-Fibrinogen Gene is Associated With the Progression of Coronary Atherosclerosis in Symptomatic Men	99
A Common Variant in the Gene for Lipoprotein Lipase (Asp9→Asn)	99
Tissue-Specific Hemostasis in Mice	98
HIV Protease Inhibitors Stimulate Hepatic Triglyceride Synthesis	98
Relationship Between Serum Sex Hormones and Coronary Artery Disease in Postmenopausal Women	98
1999 George Lyman Duff Memorial Lecture	98
Evidence That Peroxisome Proliferator–Activated Receptor Delta Influences Cholesterol Metabolism in Men	98
Role of RhoA and Rho Kinase in Lysophosphatidic Acid–Induced Endothelial Barrier Dysfunction	98
Inhibition of Arterial Thrombus Formation by ApoA1 Milano	98
HMG-CoA Reductase Inhibitor Increases GTP Cyclohydrolase I mRNA and Tetrahydrobiopterin in Vascular Endothelial Cells	98
Increased NAD(P)H Oxidase and Reactive Oxygen Species in Coronary Arteries After Balloon Injury	98
High Plasma Serotonin Levels in Primary Pulmonary Hypertension	98
Coronary Artery Disease in IDDM	98
Rosiglitazone Attenuates Atherosclerosis in a Model of Insulin Insufficiency Independent of Its Metabolic Effects	98
α-Lipoic Acid–Induced Heme Oxygenase-1 Expression Is Mediated by Nuclear Factor Erythroid 2-Related Factor 2 and p38 Mitogen-Activated Protein Kinase in Human Monocytic Cells	98
Dietary Cosupplementation With Vitamin E and Coenzyme Q ₁₀ Inhibits Atherosclerosis in Apolipoprotein E Gene Knockout Mice	98
Genetic Analysis of the IRS	98
Western-Type Diets Induce Insulin Resistance and Hyperinsulinemia in LDL Receptor-Deficient Mice But Do Not Increase Aortic Atherosclerosis Compared With Normoinsulinemic Mice in Which Similar Plasma	98
Clinical Expression of Familial Hypercholesterolemia in Clusters of Mutations of the LDL Receptor Gene That Cause a Receptor-Defective or Receptor-Negative Phenotype	98
Methamphetamine Use and Cardiovascular Disease	98
Genetic Modifiers of Atherosclerosis in Mice	97
Interleukin-8 Production by Macrophages From Atheromatous Plaques	97
Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease	97
Westernization of Chinese Adults and Increased Subclinical Atherosclerosis	97
Circulating Autoantibodies to Oxidized LDL Correlate With Arterial Accumulation and Depletion of Oxidized LDL in LDL Receptor–Deficient Mice	97
Selective Cyclooxygenase-2 Inhibition With Celecoxib Decreases Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice	97
Contribution of an In Vivo Oxidized LDL to LDL Oxidation and Its Association With Dense LDL Subpopulations	97
Pitavastatin-Induced Thrombomodulin Expression by Endothelial Cells Acts Via Inhibition of Small G Proteins of the Rho Family	97
Interleukin-6, Fibrin D-Dimer, and Coagulation Factors VII and XIIa in Prediction of Coronary Heart Disease	97
Reconstituted High-Density Lipoprotein Stimulates Differentiation of Endothelial Progenitor Cells and Enhances Ischemia-Induced Angiogenesis	97
Force Sensing by Piezo Channels in Cardiovascular Health and Disease	97
Human Secretory Phospholipase A ₂ Mediates Decreased Plasma Levels of HDL Cholesterol and ApoA-I in Response to Inflammation in Human ApoA-I Transgenic Mice	97
Paraoxonase Activity, But Not Haplotype Utilizing the Linkage Disequilibrium Structure, Predicts Vascular Disease	97
High Serum Levels of Advanced Glycation End Products Predict Increased Coronary Heart Disease Mortality in Nondiabetic Women but not in Nondiabetic Men	97
Platelets From a Patient Heterozygous for the Defect of P2 _CYC Receptors for ADP Have a Secretion Defect Despite Normal Thromboxane A ₂	97
Cyclooxygenase-2 Expression and Inhibition in Atherothrombosis	96
MnSOD Deficiency Increases Endothelial Dysfunction in ApoE-Deficient Mice	96
Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes	96
IL-18 Accelerates Atherosclerosis Accompanied by Elevation of IFN-γ and CXCL16 Expression Independently of T Cells	96
Cellular Consequences of the Association of ApoB Lipoproteins With Proteoglycans	96
Heme Oxygenase-1 Is a cGMP-Inducible Endothelial Protein and Mediates the Cytoprotective Action of Nitric Oxide	96
Serum Lipid Levels and the Risk of Venous Thrombosis	96
HIV Protease Inhibitor Ritonavir Induces Cytotoxicity of Human Endothelial Cells	96
Increased Plasma 7β-Hydroxycholesterol Concentrations in a Population With a High Risk for Cardiovascular Disease	96
C-Reactive Protein Inhibits Endothelium-Dependent NO-Mediated Dilation in Coronary Arterioles by Activating p38 Kinase and NAD(P)H Oxidase	96
Independent Mutations at Codon 3500 of the Apolipoprotein B Gene Are Associated With Hyperlipidemia	96
Oxidized LDL-Induced Smooth Muscle Cell Proliferation Involves the EGF Receptor/PI-3 Kinase/Akt and the Sphingolipid Signaling Pathways	96
Expression of Fractalkine (CX3CL1) and its Receptor, CX3CR1, Is Elevated in Coronary Artery Disease and Is Reduced During Statin Therapy	96
Reciprocal and Coordinate Regulation of Serum Amyloid A Versus Apolipoprotein A-I and Paraoxonase-1 by Inflammation in Murine Hepatocytes	96
7-Ketocholesterol Induces Protein Ubiquitination, Myelin Figure Formation, and Light Chain 3 Processing in Vascular Smooth Muscle Cells	96
Cerivastatin, an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, Inhibits Endothelial Cell Proliferation Induced by Angiogenic Factors In Vitro and Angiogenesis in In Vivo Models	96
Hypercholesterolemia in the Rabbit Induced by Feeding Graded Amounts of Low-Level Cholesterol	96
Expansive Arterial Remodeling: Location, Location, Location	95
Cytokines and Cell Adhesion Molecules in Cerebral Ischemia	95
Both Intracellular and Extracellular Vitamin C Inhibit Atherogenic Modification of LDL by Human Vascular Endothelial Cells	95
Role of Mitochondrial Permeability Transition Pore in Coated-Platelet Formation	95
Endothelium-Dependent and -Independent Vasodilation of Large Arteries in Normoalbuminuric Insulin-Dependent Diabetes Mellitus	95
Severe Periodontitis Enhances Macrophage Activation via Increased Serum Lipopolysaccharide	95
17β-Estradiol Prevents Fatty Streak Formation in Apolipoprotein E–Deficient Mice	95
Eplerenone With Valsartan Effectively Reduces Atherosclerotic Lesion by Attenuation of Oxidative Stress and Inflammation	95
Oxidized LDL Can Induce Macrophage Survival, DNA Synthesis, and Enhanced Proliferative Response to CSF-1 and GM-CSF	95
Serum Homocysteine and Risk of Coronary Heart Disease and Cerebrovascular Disease in Elderly Men	95
Effects of Granulocyte Colony Stimulating Factor on Functional Activities of Endothelial Progenitor Cells in Patients With Chronic Ischemic Heart Disease	95
Phenotypic Variation in Heterozygous Familial Hypercholesterolemia	95
HDL ₃ -Mediated Inhibition of Thrombin-Induced Platelet Aggregation and Fibrinogen Binding Occurs via Decreased Production of Phosphoinositide-Derived Second Messeng	95
Signal-Crosstalk Between Rho/ROCK and c-Jun NH ₂ -Terminal Kinase Mediates Migration of Vascular Smooth Muscle Cells Stimulated by Angiotensin II	95
Lipoprotein Retention—and Clues for Atheroma Regression	94
LDL Receptor–Related Protein Mediates Uptake of Aggregated LDL in Human Vascular Smooth Muscle Cells	94
Lifestyle and Hemostatic Risk Factors for Ischemic Heart Disease	94
Angiotensin II Stimulates the Release of Interleukin-6 and Interleukin-8 From Cultured Human Adipocytes by Activation of NF-κB	94
Vitamin E Inhibits Low-Density Lipoprotein–Induced Adhesion of Monocytes to Human Aortic Endothelial Cells In Vitro	94
Differential Expression of Chemokines, Risk of Stable Coronary Heart Disease, and Correlation with Established Cardiovascular Risk Markers	94
Distribution in Healthy and Coronary Populations of the Methylenetetrahydrofolate Reductase (MTHFR) C ₆₇₇ T Mutation	94
Membrane Potential-Dependent Inhibition of Platelet Adhesion to Endothelial Cells by Epoxyeicosatrienoic Acids	94
Lysosomal Enzymes Are Released From Cultured Human Macrophages, Hydrolyze LDL In Vitro, and Are Present Extracellularly in Human Atherosclerotic Lesions	94
2-Chlorohexadecanal Derived From Hypochlorite-Modified High-Density Lipoprotein–Associated Plasmalogen Is a Natural Inhibitor of Endothelial Nitric Oxide Biosynthesis	94
Prevalence and Correlates of Coronary Calcification in Black and White Young Adults	94
Lipoprotein-Associated Phospholipase A ₂ Is an Independent Marker for Coronary Endothelial Dysfunction in Humans	94
Dysregulation of Monocytic Nuclear Factor-κB by Oxidized Low-Density Lipoprotein	94
Haplotype-Specific Effects on Endothelial NO Synthase Promoter Efficiency	93
Neutrophil, Not Macrophage, Infiltration Precedes Neointimal Thickening in Balloon-Injured Arteries	93
Visceral Fat Accumulation and Its Relation to Plasma Hemostatic Factors in Healthy Men	93
Pioglitazone Inhibits LOX-1 Expression in Human Coronary Artery Endothelial Cells by Reducing Intracellular Superoxide Radical Generation	93
Altered Tetrahydrobiopterin Metabolism in Atherosclerosis	93
Matrix Metalloproteinase-9 Genotype Influences Large Artery Stiffness Through Effects on Aortic Gene and Protein Expression	93
Structural, Functional, and Hemodynamic Changes of the Common Carotid Artery With Age in Male Subjects	93
Clinical Significance of Small Dense Low-Density Lipoprotein Cholesterol Levels Determined by the Simple Precipitation Method	93
Smoking Impairs the Activity of Endothelial Nitric Oxide Synthase in Saphenous Vein	93
Nonnuclear Actions of Estrogen	92
Angiogenesis in Atherogenesis	92
Mechanisms of Endothelial Differentiation in Embryonic Vasculogenesis	92
Lipoprotein(a) in Homozygous Familial Hypercholesterolemia	92
Neonatal Intima Formation in the Human Coronary Artery	92
Mechanisms of Inducible Nitric Oxide Synthase–Mediated Vascular Dysfunction	92
Mineralocorticoid Receptor Activation Promotes Vascular Cell Calcification	92
HDL-Mediated Efflux of Intracellular Cholesterol Is Impaired in Fibroblasts From Tangier Disease Patients	92
Cross-Sectional Study of Soluble Intercellular Adhesion Molecule-1 and Cardiovascular Risk Factors in Apparently Healthy Men	92
A Simple Method of Plaque Rupture Induction in Apolipoprotein E–Deficient Mice	92
Reduced Postprandial Serum Paraoxonase Activity After a Meal Rich in Used Cooking Fat	92
Impaired Revascularization in a Mouse Model of Type 2 Diabetes Is Associated With Dysregulation of a Complex Angiogenic-Regulatory Network	92
Immunological Evidence for the Presence of Advanced Glycosylation End Products in Atherosclerotic Lesions of Euglycemic Rabbits	92
Differences in Insulin Suppression of Free Fatty Acid Levels by Gender and Glucose Tolerance Status	92
Common and Rare ABCA1 Variants Affecting Plasma HDL Cholesterol	92
Analysis of Macrophage Scavenger Receptor (SR-A) Expression in Human Aortic Atherosclerotic Lesions	92
Lipoprotein Response to Diets High in Soy or Animal Protein With and Without Isoflavones in Moderately Hypercholesterolemic Subjects	92
Combination of Vitamins C and E Alters the Response to Coronary Balloon Injury in the Pig	92
Serum Amyloid A and Lipoprotein Retention in Murine Models of Atherosclerosis	92
Assembly of High-Density Lipoprotein	91
Stimulated Tissue Plasminogen Activator Release as a Marker of Endothelial Function in Humans	91
Oxidative Stress Promotes Endothelial Cell Apoptosis and Loss of Microvessels in the Spontaneously Hypertensive Rats	91
Origin of Vascular Smooth Muscle Cells and the Role of Circulating Stem Cells in Transplant Arteriosclerosis	91
Statin Protects Endothelial Nitric Oxide Synthase Activity in Hypoxia-Induced Pulmonary Hypertension	91
Antibodies Against Oxidized LDL and Carotid Artery Intima-Media Thickness in a Healthy Population	91
Recombinant Leptin Promotes Atherosclerosis and Thrombosis in Apolipoprotein E–Deficient Mice	91
Mechanisms of Reactive Oxygen Species–Dependent Downregulation of Insulin Receptor Substrate-1 by Angiotensin II	91
Fibronectin and Collagen I Matrixes Promote Calcification of Vascular Cells in Vitro, Whereas Collagen IV Matrix Is Inhibitory	91
Chemokines and Incident Coronary Heart Disease	91
Regulation of the Tissue Factor Gene in Human Monocytic Cells	91
Chronic Chlamydia pneumoniae Infection Is Associated With a Serum Lipid Profile Known to Be a Risk Factor for Atherosclerosis	91
Two Common, Functional Polymorphisms in the Promoter Region of the β-Fibrinogen Gene Contribute to Regulation of Plasma Fibrinogen Concentration	91
Systemic Regulation of Vascular NAD(P)H Oxidase Activity and Nox Isoform Expression in Human Arteries and Veins	91
Association of Lipoprotein-Associated Phospholipase A ₂ Mass and Activity With Calcified Coronary Plaque in Young Adults	91
Influence of n-6 versus n-3 Polyunsaturated Fatty Acids in Diets Low in Saturated Fatty Acids on Plasma Lipoproteins and Hemostatic Factor	91
Role of ADP Receptor P2Y ₁₂ in Platelet Adhesion and Thrombus Formation in Flowing Blood	91
Role of cAMP Response Element Binding Protein in Cardiovascular Remodeling	90
Plant Sterol-Fortified Orange Juice Effectively Lowers Cholesterol Levels in Mildly Hypercholesterolemic Healthy Individuals	90
Expression of the VLDL Receptor in Endothelial Cells	90
Smooth Muscle Cell Heterogeneity in Pulmonary and Systemic Vessels	90
Dysfunction of Nitric Oxide Mediation in Isolated Rat Arterioles With Methionine Diet–Induced Hyperhomocysteinemia	90
Oncostatin M Induces Angiogenesis In Vitro and In Vivo	90
Apoptosis	90
Increased Angiotensin II Type 1 Receptor Expression in Hypercholesterolemic Atherosclerosis in Rabbits	90
Atherosclerosis, Vascular Remodeling, and Impairment of Endothelium-Dependent Relaxation in Genetically Altered Hyperlipidemic Mice	90
Coronary Heart Disease: Reducing the Risk	90
Estrogen Receptor β Protects the Murine Heart Against Left Ventricular Hypertrophy	90
Intra-Arterial Tumor Necrosis Factor-α Impairs Endothelium-Dependent Vasodilatation and Stimulates Local Tissue Plasminogen Activator Release in Humans	90
Basic Fibroblast Growth Factor–Induced Angiogenic Phenotype in Mouse Endothelium	90
Dietary and Genetic Probes of Atherogenic Dyslipidemia	89
Assessment of Unstable Atherosclerosis in Mice	89
Macrophage-Specific p53 Expression Plays a Crucial Role in Atherosclerosis Development and Plaque Remodeling	89
Genetics, Clinical Phenotype, and Molecular Cell Biology of Autosomal Recessive Hypercholesterolemia	89
Inhibition of Vascular Smooth Muscle Cell Proliferation, Migration, and Survival by the Tumor Suppressor Protein PTEN	89
Partial Off-Loading of Longitudinal Tension Induces Arterial Tortuosity	89
Ultrastructure of Early Lipid Accumulation in ApoE-Deficient Mice	89
Interferon-γ Induces Downregulation of Tangier Disease Gene (ATP-Binding-Cassette Transporter 1) in Macrophage-Derived Foam Cells	89
Immunohistochemical Expression of Vascular Endothelial Growth Factor/Vascular Permeability Factor in Atherosclerotic Intimas of Human Coronary Arteries	89
Human Vascular Smooth Muscle Cells Express Receptors for CC Chemokines	89
ADAM17 Mediates Epidermal Growth Factor Receptor Transactivation and Vascular Smooth Muscle Cell Hypertrophy Induced by Angiotensin II	89
Long-Term Inhibition of Rho-Kinase Suppresses Neointimal Formation After Stent Implantation in Porcine Coronary Arteries: Involvement of Multiple Mechanisms	89
Granzyme B Induces Smooth Muscle Cell Apoptosis in the Absence of Perforin	89
Fibrinogen and Silent Atherosclerosis in Subjects With Cardiovascular Risk Factors	88
Thrombin Promotes Activation of Matrix Metalloproteinase-2 Produced by Cultured Vascular Smooth Muscle Cells	88
Mildly Oxidized LDL Induces Platelet Aggregation Through Activation of Phospholipase A ₂	88
Similarities and Differences in Smooth Muscle α-Actin Induction by TGF-β in Smooth Muscle Versus Non–Smooth Muscle Cells	88
Asymmetric Dimethylarginine Increases Mononuclear Cell Adhesiveness in Hypercholesterolemic Humans	88
Mast Cell Chymase Induces Smooth Muscle Cell Apoptosis by a Mechanism Involving Fibronectin Degradation and Disruption of Focal Adhesions	88
Gallates Inhibit Cytokine-Induced Nuclear Translocation of NF-κB and Expression of Leukocyte Adhesion Molecules in Vascular Endothelial Cells	88
Influence of PAI-1 on Adipose Tissue Growth and Metabolic Parameters in a Murine Model of Diet-Induced Obesity	88
Quantitative and Qualitative Differences in Proatherogenic NKT Cells in Apolipoprotein E–Deficient Mice	88
Cholesterol Enrichment of Human Monocyte/Macrophages Induces Surface Exposure of Phosphatidylserine and the Release of Biologically-Active Tissue Factor–Positive Microvesicles	88
C-Peptide Colocalizes with Macrophages in Early Arteriosclerotic Lesions of Diabetic Subjects and Induces Monocyte Chemotaxis In Vitro	88
No Effect of C-Reactive Protein on Early Atherosclerosis Development in Apolipoprotein E*3-Leiden/Human C-Reactive Protein Transgenic Mice	88
In Vivo Plaque Characterization Using Intravascular Ultrasound–Virtual Histology in a Porcine Model of Complex Coronary Lesions	88
Polymorphisms of the Human Matrix Gla Protein ( MGP ) Gene, Vascular Calcification, and Myocardial Infarction	88
Histone Deacetylase Inhibitor Reduces Monocyte Adhesion to Endothelium Through the Suppression of Vascular Cell Adhesion Molecule-1 Expression	88
A Negative Carotid Plaque Area Test Is Superior to Other Noninvasive Atherosclerosis Studies for Reducing the Likelihood of Having Underlying Significant Coronary Artery Disease	88
Regulation of Human ApoA-I by Gemfibrozil and Fenofibrate Through Selective Peroxisome Proliferator-Activated Receptor α Modulation	88